Ogni anno, più di 350.000 nuovi casi di tumore del rene vengono diagnosticati nel mondo. L’incidenza della patologia (il termine che in medicina indica il numero di nuove diagnosi ogni anno) sta aumentando progressivamente, in particolare nei Paesi Occidentali, dove fattori predisponenti comportamentali (soprattutto fumo e obesità) e ambientali (in particolare sostanze inquinanti) stanno determinando un aumento del rischio di sviluppare la malattia. Numerosi aspetti di predisposizione genetica sono stati chiariti (ad esempio le mutazioni a carico di un gene chiamato VHL) anche se la maggior parte dei casi il tumore si sviluppa in assenza di ereditarietà familiare. La malattia colpisce sia gli uomini che le donne e soprattutto tra i 50 e i 70 anni di età, nonostante esistano molti casi diagnosticati anche in soggetti molto più giovani. Spesso il tumore al rene viene scoperto per caso, durante esami eseguiti per altri motivi (ad esempio una ecografia dell'addome) in assenza di sintomi evidenti. In questi casi la prognosi è generalmente molto buona con una guarigione completa dopo trattamento medico da parte dell'urologo. In un terzo circa dei casi, il tumore si identifica purtroppo per la presenza di sintomi (ad esempio dolore al fianco, sangue nelle urine, febbre di origine sconosciuta) che sono spesso secondari alla presenza di una malattia localmente avanzata o addirittura metastatica. In questi casi, la prognosi è purtroppo compromessa dalla presenza di una malattia molto più aggressiva.
Nel passato, nei casi in cui veniva riscontrata una "massa anomala" del rene, il paziente veniva sottoposto a interventi chirurgici demolitivi e invasivi che comportavano una grossa incisione addominale, la rimozione di tutto il rene e della ghiandola surrenalica (un piccolo organo che si trova sopra al rene e che è responsabile di produrre ormoni). Oggi giorno, i dati scientifici hanno ormai confermato che in molti casi si può intervenire rimuovendo solo la parte del rene malato oppure sottoporre il paziente a trattamenti alternativi (ad esempio bruciando o congelando il tumore per via percutanea, cioè inserendo un ago attraverso la cute). In alcuni casi particolari, il paziente può addirittura andare incontro alla semplice osservazione nel tempo poiché, soprattutto quando diagnosticati precocemente e di piccole dimensioni, le masse renali risultano spesso malattie benigne o a bassa aggressività.
Quando l'intervento diventa necessario, il miglioramento delle tecniche chirurgiche mini-invasive (soprattutto laparoscopia e chirurgia robotica) ha diminuito l’impatto delle terapie sul decorso post-operatorio e sulla qualità di vita nel lungo periodo. Infine, lo sviluppo di nuovi farmaci biologici e la loro integrazione con la terapia chirurgica stanno contribuendo a migliorare il controllo oncologico anche nei casi di malattie già metastatiche alla diagnosi.
In conclusione, oggigiorno il tumore del rene rappresenta uno di quegli esempi in medicina dove gli sforzi nella ricerca clinica e di base hanno permesso di fare passi da gigante, migliorando non solo la sopravvivenza degli ammalati ma anche la qualità di vita dei pazienti. Fondamentale è tuttavia condurre uno stile di vita sano e sottoporsi ai controlli medici periodici, specialmente nei soggetti a rischio (fumatori, ipertesi, sovrappeso, soggetti con familiarità positiva per patologia renale). Inoltre, mai sottovalutare i segnali del nostro corpo: in caso di comparsa di nuovi sintomi è consigliabile una valutazione del proprio medico di famiglia e una eventuale visita specialistica urologica nel caso si sospetti la presenza di una patologia renale.
Di seguito sono riportati alcuni degli articoli scientifici pubblicati dal dr. Capitanio nell'ambito del tumore del rene (Fonte: Pubmed-Scopus 2023):
1: CAPITANIO U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J, Gore JL, Sun
M, Wood C, Russo P. Epidemiology of Renal Cell Carcinoma. Eur Urol. 2019
Jan;75(1):74-84. doi: 10.1016/j.eururo.2018.08.036. Epub 2018 Sep 19. PMID:
30243799; PMCID: PMC8397918.
2: CAPITANIO U, Montorsi F. Renal cancer. Lancet. 2016 Feb
27;387(10021):894-906. doi: 10.1016/S0140-6736(15)00046-X. Epub 2015 Aug 25.
PMID: 26318520.
3: Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, CAPITANIO U, Dabestani S,
Fernández-Pello S, Giles RH, Hofmann F, Hora M, Klatte T, Kuusk T, Lam TB,
Marconi L, Powles T, Tahbaz R, Volpe A, Bex A. European Association of Urology
Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. 2022
Oct;82(4):399-410. doi: 10.1016/j.eururo.2022.03.006. Epub 2022 Mar 26. PMID:
35346519.
4: Rosiello G, Larcher A, Montorsi F, CAPITANIO U. Renal cancer: overdiagnosis
and overtreatment. World J Urol. 2021 Aug;39(8):2821-2823. doi:
10.1007/s00345-021-03798-z. PMID: 34383133.
5: Martini A, Fallara G, Pellegrino F, Cirulli GO, Larcher A, Necchi A, Montorsi
F, CAPITANIO U. Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma.
World J Urol. 2021 May;39(5):1369-1376. doi: 10.1007/s00345-020-03550-z. Epub
2021 Jan 1. PMID: 33386494.
6: Roussel E, CAPITANIO U, Kutikov A, Oosterwijk E, Pedrosa I, Rowe SP, Gorin
MA. Novel Imaging Methods for Renal Mass Characterization: A Collaborative
Review. Eur Urol. 2022 May;81(5):476-488. doi: 10.1016/j.eururo.2022.01.040.
Epub 2022 Feb 22. PMID: 35216855; PMCID: PMC9844544.
7: Bedke J, Albiges L, CAPITANIO U, Giles RH, Hora M, Lam TB, Ljungberg B,
Marconi L, Klatte T, Volpe A, Abu-Ghanem Y, Dabestani S, Pello SF, Hofmann F,
Kuusk T, Tahbaz R, Powles T, Bex A. The 2021 Updated European Association of
Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor-based
Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell
Carcinoma Are Standard of Care. Eur Urol. 2021 Oct;80(4):393-397. doi:
10.1016/j.eururo.2021.04.042. Epub 2021 May 29. PMID: 34074559.
8: Campi R, Stewart GD, Staehler M, Dabestani S, Kuczyk MA, Shuch BM, Finelli A,
Bex A, Ljungberg B, CAPITANIO U. Novel Liquid Biomarkers and Innovative Imaging
for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A
Systematic Review of the Literature. Eur Urol Oncol. 2021 Feb;4(1):22-41. doi:
10.1016/j.euo.2020.12.011. Epub 2021 Jan 3. PMID: 33408053.
9: Stabile A, Muttin F, Zamboni S, Moschini M, Gandaglia G, Fossati N,
Dell'Oglio P, CAPITANIO U, Cucchiara V, Mazzone E, Bravi CA, Mirone V, Montorsi
F, Briganti A. Therapeutic approaches for lymph node involvement in prostate,
bladder and kidney cancer. Expert Rev Anticancer Ther. 2019 Sep;19(9):739-755.
doi: 10.1080/14737140.2019.1659135. Epub 2019 Aug 30. PMID: 31469021.
10: CAPITANIO U, Larcher A, Cianflone F, Trevisani F, Nini A, Mottrie A, Mari A,
Campi R, Tellini R, Briganti A, Veccia A, Van Poppel H, Carini M, Simeone C,
Salonia A, Minervini A, Antonelli A, Montorsi F, Bertini R. Hypertension and
Cardiovascular Morbidity Following Surgery for Kidney Cancer. Eur Urol Oncol.
2020 Apr;3(2):209-215. doi: 10.1016/j.euo.2019.02.006. Epub 2019 Mar 25. PMID:
31411993.
11: Ingels A, Campi R, CAPITANIO U, Amparore D, Bertolo R, Carbonara U, Erdem S,
Kara Ö, Klatte T, Kriegmair MC, Marchioni M, Mir MC, Ouzaïd I, Pavan N, Pecoraro
A, Roussel E, de la Taille A. Complementary roles of surgery and systemic
treatment in clear cell renal cell carcinoma. Nat Rev Urol. 2022
Jul;19(7):391-418. doi: 10.1038/s41585-022-00592-3. Epub 2022 May 11. PMID:
35546184.
12: CAPITANIO U, Rosiello G, Erdem S, Rowe I, Kara O, Roussel E, Campi R, Klatte
T, Kriegmair MC, Sibona M, Bertolo R, Ouzaid I, Mir MC, Marra G, Larcher A,
Montorsi F, Salonia A; Kidney Cancer Working Group of the Young Academic
Urologists (YAU) Working Party of the European Association of Urology (EAU).
Clinical, surgical, pathological and follow-up features of kidney cancer
patients with Von Hippel-Lindau syndrome: novel insights from a large
consortium. World J Urol. 2021 Aug;39(8):2969-2975. doi:
10.1007/s00345-020-03574-5. Epub 2021 Jan 8. PMID: 33416974.
13: CAPITANIO U, Fallara G, Raggi D, Nocera L, Larcher A, Belladelli F, Rowe I,
Briganti A MD,PhD, Salonia A MD,PhD, Karakiewicz P, Montorsi F, Martini A,
Necchi A. Pembrolizumab in advanced renal cell carcinoma: a meta-analysis
providing level 1a evidence. Curr Probl Cancer. 2022 Aug;46(4):100875. doi:
10.1016/j.currproblcancer.2022.100875. Epub 2022 Jun 1. PMID: 35679628.
14: Campi R, Rebez G, Klatte T, Roussel E, Ouizad I, Ingels A, Pavan N, Kara O,
Erdem S, Bertolo R, CAPITANIO U, Mir MC. Effect of smoking, hypertension and
lifestyle factors on kidney cancer - perspectives for prevention and screening
programmes. Nat Rev Urol. 2023 Jun 16. doi: 10.1038/s41585-023-00781-8. Epub
ahead of print. PMID: 37328546.
15: Kriegmair MC, Bertolo R, Karakiewicz PI, Leibovich BC, Ljungberg B, Mir MC,
Ouzaid I, Salagierski M, Staehler M, van Poppel H, Wood CC, CAPITANIO U; Young
Academic Urologists Kidney Cancer working group of the European Association of
Urology. Systematic Review of the Management of Local Kidney Cancer Relapse. Eur
Urol Oncol. 2018 Dec;1(6):512-523. doi: 10.1016/j.euo.2018.06.007. Epub 2018 Jul
13. PMID: 31158097.
16: Larcher A, Sun M, Dell'Oglio P, Trudeau V, Boehm K, Schiffmann J, Tian Z,
Fossati N, CAPITANIO U, Briganti A, Montorsi F, Karakiewicz P. Mortality,
morbidity and healthcare expenditures after local tumour ablation or partial
nephrectomy for T1A kidney cancer. Eur J Surg Oncol. 2017 Apr;43(4):815-822.
doi: 10.1016/j.ejso.2016.08.023. Epub 2016 Sep 17. PMID: 27692535.
17: Bedke J, Albiges L, CAPITANIO U, Giles RH, Hora M, Ljungberg B, Marconi L,
Klatte T, Volpe A, Abu-Ghanem Y, Dabestani S, Fernández-Pello S, Hofmann F,
Kuusk T, Tahbaz R, Powles T, Bex A. The 2022 Updated European Association of
Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy
for Renal Cell Carcinoma. Eur Urol. 2023 Jan;83(1):10-14. doi:
10.1016/j.eururo.2022.10.010. Epub 2022 Oct 27. PMID: 36511268.
18: Marra G, Gontero P, Brattoli M, Filippini C, CAPITANIO U, Montorsi F,
Daneshmand S, Huang WC, Linares Espinós E, Martínez-Salamanca JI, McKiernan JM,
Zigeuner R, Libertino JA. Is imperative partial nephrectomy feasible for kidney
cancer with venous thrombus involvement? Outcomes of 42 cases and matched pair
analysis with a large radical nephrectomy cohort. Urol Oncol. 2018
Jul;36(7):339.e1-339.e8. doi: 10.1016/j.urolonc.2018.04.007. Epub 2018 May 24.
PMID: 29801993.
19: Nocera L, Collà Ruvolo C, Stolzenbach LF, Wenzel M, Tian Z, Larcher A,
CAPITANIO U, Mirone V, Tilki D, Chun FKH, Kapoor A, Shariat SF, Saad F, Montorsi
F, Briganti A, Karakiewicz PI. Tumor Stage and Substage Predict Cancer-specific
Mortality After Nephrectomy for Nonmetastatic Renal Cancer: Histological
Subtype-specific Validation. Eur Urol Focus. 2022 Jan;8(1):182-190. doi:
10.1016/j.euf.2021.02.009. Epub 2021 Feb 27. PMID: 33653677.
20: Veccia A, Antonelli A, Minervini A, Mottrie A, Dell'Oglio P, Ashrafi AN,
Larcher A, Eun D, Bradshaw A, Amparore D, Brassetti A, Hampton LJ, Simeone C,
Mari A, Carini M, De Naeyer G, Yang K, CAPITANIO U, Simone G, Porpiglia F,
Derweesh I, Aron M, Autorino R. Upstaging to pT3a disease in patients undergoing
robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from
a multi-institutional dataset. Urol Oncol. 2020 Apr;38(4):286-292. doi:
10.1016/j.urolonc.2019.12.024. Epub 2020 Jan 16. PMID: 31956077.
21: CAPITANIO U, Bedke J, Albiges L, Volpe A, Giles RH, Hora M, Marconi L,
Klatte T, Abu-Ghanem Y, Dabestani S, Fernández Pello S, Hofmann F, Kuusk T,
Campi R, Tahbaz R, Powles T, Ljungberg B, Bex A. Reply to Yaxiong Tang, Xu Hu,
Kan Wu, Yanxiang Shao, and Xiang Li's Letter to the Editor re: Umberto
Capitanio, Jens Bedke, Laurence Albiges, et al. A Renewal of the TNM Staging
System for Patients with Renal Cancer To Comply with Current Decision-making:
Proposal from the European Association of Urology Guidelines Panel. Eur Urol.
2022;83:3-5. Eur Urol. 2023 Mar;83(3):e74-e75. doi:
10.1016/j.eururo.2022.12.001. Epub 2022 Dec 14. PMID: 36526491.
22: Mir MC, CAPITANIO U, Bertolo R, Ouzaid I, Salagierski M, Kriegmair M, Volpe
A, Jewett MAS, Kutikov A, Pierorazio PM; Young Academic Urologists Kidney Cancer
working group of the European Urological Association. Role of Active
Surveillance for Localized Small Renal Masses. Eur Urol Oncol. 2018
Aug;1(3):177-187. doi: 10.1016/j.euo.2018.05.001. Epub 2018 May 26. PMID:
31102618.
23: Bandini M, Smith A, Marchioni M, Pompe RS, Martel TF, Cindolo L, Montorsi F,
Shariat SF, Briganti A, Kapoor A, CAPITANIO U, Karakiewicz PI. Adjuvant
Therapies in Nonmetastatic Renal-Cell Carcinoma: A Review of the Literature.
Clin Genitourin Cancer. 2018 Jun;16(3):176-183. doi: 10.1016/j.clgc.2018.01.003.
Epub 2018 Feb 2. PMID: 29449091.
24: Larcher A, Rowe I, Belladelli F, Fallara G, Raggi D, Necchi A, Montorsi F,
CAPITANIO U, Salonia A; OSR VHL Program. Von Hippel-Lindau disease-associated
renal cell carcinoma: a call to action. Curr Opin Urol. 2022 Jan 1;32(1):31-39.
doi: 10.1097/MOU.0000000000000950. PMID: 34783716.
25: CAPITANIO U, Leibovich BC. The rationale and the role of lymph node
dissection in renal cell carcinoma. World J Urol. 2017 Apr;35(4):497-506. doi:
10.1007/s00345-016-1886-3. Epub 2016 Jun 30. PMID: 27364520.
26: Capogrosso P, CAPITANIO U, La Croce G, Nini A, Salonia A, Montorsi F,
Bertini R. Follow-up After Treatment for Renal Cell Carcinoma: The Evidence
Beyond the Guidelines. Eur Urol Focus. 2016 Feb;1(3):272-281. doi:
10.1016/j.euf.2015.04.001. Epub 2015 Jun 1. PMID: 28723399.
27: Cignoli D, Fallara G, Larcher A, Rosiello G, Montorsi F, CAPITANIO U. How to
improve outcome in nephron-sparing surgery: the impact of new techniques. Curr
Opin Urol. 2021 May 1;31(3):255-261. doi: 10.1097/MOU.0000000000000862. PMID:
33742985.
28: Carbonara U, Simone G, CAPITANIO U, Minervini A, Fiori C, Larcher A,
Checcucci E, Amparore D, Crocerossa F, Veccia A, Weprin S, Ditonno P, Brassetti
A, Bove A, Mari A, Grosso AA, Carini M, Montorsi F, Hampton LJ, Gallucci M,
Porpiglia F, Autorino R. Robot-assisted partial nephrectomy: 7-year outcomes.
Minerva Urol Nephrol. 2021 Aug;73(4):540-543. doi:
10.23736/S2724-6051.20.04151-X. Epub 2020 Nov 17. PMID: 33200907.
29: Capasso A, Benigni A, CAPITANIO U, Danesh FR, Di Marzo V, Gesualdo L,
Grandaliano G, Jaimes EA, Malyszko J, Perazella MA, Qian Q, Ronco P, Rosner MH,
Trepiccione F, Viggiano D, Zoccali C, Capasso G; International Conference on
Onco-Nephrology Participants. Summary of the International Conference on Onco-
Nephrology: an emerging field in medicine. Kidney Int. 2019 Sep;96(3):555-567.
doi: 10.1016/j.kint.2019.04.043. Epub 2019 May 31. PMID: 31445584.
30: Mantione ME, Sana I, Vilia MG, Riba M, Doglioni C, Larcher A, CAPITANIO U,
Muzio M. SIGIRR Downregulation and Interleukin-1 Signaling Intrinsic to Renal
Cell Carcinoma. Front Oncol. 2022 Jun 22;12:894413. doi:
10.3389/fonc.2022.894413. PMID: 35814450; PMCID: PMC9256934.
31: CAPITANIO U, Volpe A. Renal Tumor Biopsy: More Dogma Belied. Eur Urol. 2015
Dec;68(6):1014-5. doi: 10.1016/j.eururo.2015.05.007. Epub 2015 May 21. PMID:
26004797.
32: Borgmann H, Musquera M, Haferkamp A, Vilaseca A, Klatte T, Shariat SF,
Scavuzzo A, Jimenez Rios MA, Wolff I, CAPITANIO U, Dell'Oglio P, Krabbe LM,
Herrmann E, Ecke T, Vergho D, Huck N, Wagener N, Pahernik S, Zastrow S, Wirth M,
Surcel C, Mirvald C, Prochazkova K, Hutterer G, Zigeuner R, Cindolo L, Hora M,
Stief CG, May M, Brookman-May SD. Prognostic significance of Fuhrman grade and
age for cancer-specific and overall survival in patients with papillary renal
cell carcinoma: results of an international multi-institutional study on 2189
patients. World J Urol. 2017 Dec;35(12):1891-1897. doi:
10.1007/s00345-017-2078-5. Epub 2017 Aug 23. PMID: 28836063.
33: Marchioni M, Berardinelli F, Zhang C, Simone G, Uzzo RG, CAPITANIO U,
Minervini A, Lau C, Kaouk J, Langenstroer P, Amparore D, de Luyk N, Porter J,
Gallucci M, Kutikov A, Larcher A, Mari A, Kilday P, Rha KH, Quarto G, Perdonà S,
White W, Eun DD, Derweesh I, Mottrie A, Anele UA, Jacobsohn K, Porpiglia F,
Challacombe B, Sundaram CP, Autorino R, Yang B, Schips L. Effect of Obesity and
Overweight Status on Complications and Survival After Minimally Invasive Kidney
Surgery in Patients with Clinical T<sub>2-4</sub> Renal Masses. J Endourol. 2020
Mar;34(3):289-297. doi: 10.1089/end.2019.0604. PMID: 31950886.
34: Larcher A, Trudeau V, Sun M, Boehm K, Meskawi M, Tian Z, Fossati N,
Dell'Oglio P, CAPITANIO U, Briganti A, Shariat SF, Montorsi F, Karakiewicz PI.
Population-based assessment of cancer-specific mortality after local tumour
ablation or observation for kidney cancer: a competing risks analysis. BJU Int.
2016 Oct;118(4):541-6. doi: 10.1111/bju.13326. Epub 2015 Oct 16. PMID: 26384713.
35: Brassetti A, Anceschi U, Bertolo R, Ferriero M, Tuderti G, CAPITANIO U,
Larcher A, Garisto J, Antonelli A, Mottire A, Minervini A, Dell'oglio P, Veccia
A, Amparore D, Flammia RS, Mari A, Porpiglia F, Montorsi F, Kaouk J, Autorino R,
Carini M, Gallucci M, Simone G. Surgical quality, cancer control and functional
preservation: introducing a novel trifecta for robot-assisted partial
nephrectomy. Minerva Urol Nefrol. 2020 Feb;72(1):82-90. doi:
10.23736/S0393-2249.19.03570-7. Epub 2019 Dec 12. PMID: 31833720.
36: Marandino L, Raggi D, Necchi A, CAPITANIO U. Neoadjuvant Treatment in Renal
Cell Carcinoma: Transforming Challenges into Opportunities. Eur Urol. 2022
Jun;81(6):574-575. doi: 10.1016/j.eururo.2022.02.013. Epub 2022 Mar 2. PMID:
35248412.
37: Ventimiglia E, Larcher A, Trevisani F, Muttin F, Cianflone F, Montorsi F,
Salonia A, Bertini R, CAPITANIO U. Postoperative complications increase the risk
of long-term chronic kidney disease after nephron-sparing surgery in patients
with renal cancer and normal preoperative renal function. BJU Int. 2019
Sep;124(3):457-461. doi: 10.1111/bju.14712. Epub 2019 Mar 20. PMID: 30768877.
38: Larcher A, Cei F, Belladelli F, Rosiello G, Andrea Bravi C, Fallara G,
Basile G, Lucianò R, Karakiewicz P, Mottrie A, Breda A, Briganti A, Salonia A,
Bertini R, Montorsi F, CAPITANIO U; Junior ERUS/Young Academic Urologists
Working Group on Robotic Surgery. The Learning Curve for Radical Nephrectomy for
Kidney Cancer: Implications for Surgical Training. Eur Urol Open Sci. 2023 Jan
19;49:11-14. doi: 10.1016/j.euros.2022.12.007. PMID: 36874599; PMCID:
PMC9975008.
39: Martini A, Larcher A, Bravi CA, Capogrosso P, Falagario UG, Fallara G,
Pellegrino F, Muttin F, Re C, Briganti A, Salonia A, Bertini R, Montorsi F,
CAPITANIO U; Young Academic Urologists working groups on robotic surgery and
kidney cancer of the European Association of Urology. How to Select the Optimal
Candidates for Renal Mass Biopsy. Eur Urol Oncol. 2021 Jun;4(3):506-509. doi:
10.1016/j.euo.2020.10.001. Epub 2020 Oct 21. PMID: 34074486.
40: Chandrasekar T, Boorjian SA, CAPITANIO U, Gershman B, Mir MC, Kutikov A.
Collaborative Review: Factors Influencing Treatment Decisions for Patients with
a Localized Solid Renal Mass. Eur Urol. 2021 Nov;80(5):575-588. doi:
10.1016/j.eururo.2021.01.021. Epub 2021 Feb 6. PMID: 33558091.
41: CAPITANIO U, Necchi A, Larcher A, De Cobelli F, Montorsi F. Adjuvant Therapy
in Nonmetastatic High-risk Kidney Cancer: Importance of the Timing of
Postnephrectomy Imaging and Treatment Delivery. Eur Urol Oncol. 2018
Dec;1(6):538-539. doi: 10.1016/j.euo.2018.06.003. Epub 2018 Jul 2. PMID:
31158101.
42: Rosiello G, Pecoraro A, Deuker M, Stolzenbach LF, Martin T, Tian Z, Larcher
A, CAPITANIO U, Montorsi F, Shariat SF, Kapoor A, Saad F, Briganti A,
Karakiewicz PI. The impact of sex and age on distribution of metastases in
patients with renal cell carcinoma. Int J Clin Oncol. 2021 May;26(5):962-970.
doi: 10.1007/s10147-021-01874-3. Epub 2021 Jan 30. PMID: 33515351.
43: Rodriguez Faba O, Akdogan B, Marszalek M, Langenhuijsen JF, Brookman-May S,
Stewart GD, CAPITANIO U, Sanguedolce F; Renal Cancer Working Group of the Young
Academic Urologists (YAU) Working Party of the European Association of Urology
(EAU). Current Status of Focal Cryoablation for Small Renal Masses. Urology.
2016 Apr;90:9-15. doi: 10.1016/j.urology.2015.11.041. Epub 2015 Dec 29. PMID:
26743392.
44: Nini A, Muttin F, Cianflone F, Carenzi C, Luciano R, Catena M, Larcher A,
Salvioni M, Cazzaniga W, Pederzoli F, Matloob R, Colombo R, Paganelli M, Salonia
A, Briganti A, Doglioni C, Zangrillo A, DE Cobelli F, Rigatti P, Freschi M,
Cornero G, Nicoletti R, Aldrighetti L, Montorsi F, CAPITANIO U, Bertini R.
Perioperative and oncologic outcomes of open radical nephrectomy and inferior
vena cava thrombectomy with liver mobilization and Pringle maneuver for Mayo III
level tumor thrombus: single institution experience. Minerva Urol Nephrol. 2021
Dec;73(6):746-753. doi: 10.23736/S2724-6051.20.03844-8. Epub 2020 Nov 27. PMID:
33242949.
45: Derweesh IH, Autorino R, Bensalah K, CAPITANIO U. Partial Nephrectomy for
Large or Complex Masses: Option or Obsolete? Eur Urol. 2017 Jul;72(1):76-77.
doi: 10.1016/j.eururo.2017.01.032. Epub 2017 Feb 6. PMID: 28185688.
46: Basile G, Rosiello G, Larcher A, Fallara G, Martini A, Re C, Cignoli D, Tian
Z, Karakiewicz PI, Mottrie A, Bertini R, Necchi A, Raggi D, Salonia A, Briganti
A, Montorsi F, CAPITANIO U. Clinical, pathological and long-term oncologic
outcomes of papillary type I vs. type II renal cell carcinoma. Urol Oncol. 2022
Aug;40(8):384.e15-384.e21. doi: 10.1016/j.urolonc.2022.05.012. Epub 2022 May 31.
PMID: 35662498.
47: Sharma G, Shah M, Ahluwalia P, Dasgupta P, Challacombe BJ, Bhandari M,
Ahlawat R, Rawal S, Buffi NM, Sivaraman A, Porter JR, Rogers C, Mottrie A, Abaza
R, Rha KH, Moon D, Yuvaraja TB, Parekh DJ, CAPITANIO U, Maes KK, Porpiglia F,
Turkeri L, Gautam G. Perioperative outcomes following robot-assisted partial
nephrectomy in elderly patients. World J Urol. 2022 Nov;40(11):2789-2798. doi:
10.1007/s00345-022-04171-4. Epub 2022 Oct 6. PMID: 36203102.
48: Moschini M, Dell'Oglio P, Larcher A, CAPITANIO U. Lymph node dissection for
renal cell carcinoma: what are we missing? Curr Opin Urol. 2016
Sep;26(5):424-31. doi: 10.1097/MOU.0000000000000312. PMID: 27262140.
49: Neves JB, Vanaclocha Saiz L, Abu-Ghanem Y, Marchetti M, Tran-Dang MA, El-
Sheikh S, Barod R, Beisland C, CAPITANIO U, Cullen D, Klatte T, Ljungberg B,
Mumtaz F, Patki P, Stewart GD, Dabestani S, Tran MGB, Bex A; RECUR consortium.
Pattern, timing and predictors of recurrence after surgical resection of
chromophobe renal cell carcinoma. World J Urol. 2021 Oct;39(10):3823-3831. doi:
10.1007/s00345-021-03683-9. Epub 2021 Apr 13. PMID: 33851271.
50: CAPITANIO U, Bedke J, Albiges L, Volpe A, Giles RH, Hora M, Marconi L,
Klatte T, Abu-Ghanem Y, Dabestani S, Fernández Pello S, Hofmann F, Kuusk T,
Tahbaz R, Powles T, Ljungberg B, Bex A. A Renewal of the TNM Staging System for
Patients with Renal Cancer To Comply with Current Decision-making: Proposal from
the European Association of Urology Guidelines Panel. Eur Urol. 2023
Jan;83(1):3-5. doi: 10.1016/j.eururo.2022.09.026. Epub 2022 Oct 15. PMID:
36253306.
51: Salagierski M, Wojciechowska A, Zając K, Klatte T, Thompson RH, Cadeddu JA,
Kaouk J, Autorino R, Ahrar K, CAPITANIO U; Young Academic Urologists Kidney
Cancer Working Group of the European Urological Association. The Role of
Ablation and Minimally Invasive Techniques in the Management of Small Renal
Masses. Eur Urol Oncol. 2018 Oct;1(5):395-402. doi: 10.1016/j.euo.2018.08.029.
Epub 2018 Sep 24. PMID: 31158078.
52: Khene ZE, Mazouin C, Larcher A, Peyronnet B, Gasmi A, Roumiguié M, Verhoest
G, CAPITANIO U, Mathieu R, Doumerc N, Montorsi F, Bensalah K. Predicting
Complications After Robotic Partial Nephrectomy: Back to Simplicity. Eur Urol
Focus. 2022 May;8(3):777-783. doi: 10.1016/j.euf.2021.04.017. Epub 2021 May 3.
PMID: 33958318.
53: Larcher A, Trudeau V, Dell'Oglio P, Tian Z, Boehm K, Fossati N, CAPITANIO U,
Briganti A, Montorsi F, Karakiewicz P. Prediction of Competing Mortality for
Decision-making Between Surgery or Observation in Elderly Patients With T1
Kidney Cancer. Urology. 2017 Apr;102:130-137. doi:
10.1016/j.urology.2016.08.069. Epub 2016 Nov 21. PMID: 27884597.
54: CAPITANIO U, Montorsi F, Larcher A. Surgical Safety of Cytoreductive
Nephrectomy Following Systemic Therapy: What Should We Look For? Eur Urol. 2019
Oct;76(4):441-442. doi: 10.1016/j.eururo.2019.07.007. Epub 2019 Jul 18. PMID:
31327639.
55: Neves JB, Varley R, Agnesi S, Withington J, Rodrigues FB, Warren H, Yuminaga
Y, CAPITANIO U, Rode N, Grant L, Tran-Dang MA, El-Sheikh S, Walkden M, Cullen D,
Aitchison M, Patki P, Mumtaz F, Barod R, Bex A, Tran MGB. Growth and renal
function dynamics of renal oncocytomas in patients on active surveillance. BJU
Int. 2021 Dec;128(6):722-727. doi: 10.1111/bju.15499. Epub 2021 Aug 9. PMID:
34046981.
56: Campi R, Amparore D, CAPITANIO U, Checcucci E, Salonia A, Fiori C, Minervini
A, Briganti A, Carini M, Montorsi F, Serni S, Porpiglia F. Assessing the Burden
of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies
During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral
Centres. Eur Urol. 2020 Jul;78(1):11-15. doi: 10.1016/j.eururo.2020.03.054. Epub
2020 Apr 11. PMID: 32307215; PMCID: PMC7151319.
57: Nini A, CAPITANIO U, Larcher A, Dell'Oglio P, Dehò F, Suardi N, Muttin F,
Carenzi C, Freschi M, Lucianò R, La Croce G, Briganti A, Colombo R, Salonia A,
Castiglioni A, Rigatti P, Montorsi F, Bertini R. Perioperative and Oncologic
Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation
and Deep Hypothermic Circulatory Arrest for Renal Cell Carcinoma Invading the
Supradiaphragmatic Inferior Vena Cava and/or Right Atrium. Eur Urol. 2018
May;73(5):793-799. doi: 10.1016/j.eururo.2017.08.019. Epub 2017 Sep 13. PMID:
28917595.
58: Bravi CA, Rosiello G, Mazzone E, Minervini A, Mari A, Di Maida F, Bensalah
K, Peyronnet B, Khene ZE, Schiavina R, Bianchi L, Mottrie A, De Naeyer G,
Antonelli A, Furlan M, Rha KH, Almujalhem A, Derweesh I, Bradshaw A, Kaouk J,
Sawczyn G, Bertolo R, Breda A, Montorsi F, CAPITANIO U, Larcher A; Junior
ERUS/Young Academic Urologist Working Group on Robot-assisted Surgery. The IRON
Study: Investigation of Robot-assisted Versus Open Nephron-sparing Surgery. Eur
Urol Open Sci. 2023 Jan 30;49:71-77. doi: 10.1016/j.euros.2022.12.017. PMID:
36874602; PMCID: PMC9974968.
59: CAPITANIO U, Montorsi F. Identifying patients for adjuvant therapy after
nephrectomy. Lancet. 2022 Oct 1;400(10358):1080-1081. doi:
10.1016/S0140-6736(22)01747-0. Epub 2022 Sep 10. PMID: 36099928.
60: Rosiello G, Palumbo C, Deuker M, Stolzenbach LF, Martin T, Tian Z, Larcher
A, CAPITANIO U, Montorsi F, Shariat SF, Kapoor A, Saad F, Briganti A,
Karakiewicz PI. Partial nephrectomy in frail patients: Benefits of robot-
assisted surgery. Surg Oncol. 2021 Sep;38:101588. doi:
10.1016/j.suronc.2021.101588. Epub 2021 Apr 22. PMID: 33945961.
61: Antonelli A, Minervini A, CAPITANIO U. Reply to Steven C. Campbell,
Chalairat Suk-Ouichai, and Yun-Lin Ye's Words of Wisdom re: Below Safety Limits,
Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship
between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma.
Antonelli A, Minervini A, Sandri M, et al. Eur Urol 2018;74:661-7 and
2019;75:198. Eur Urol. 2019 Jul;76(1):e17-e18. doi:
10.1016/j.eururo.2019.01.028. Epub 2019 Jan 31. PMID: 30711331.
62: Fallara G, Larcher A, Dabestani S, Fossati N, Järvinen P, Nisen H,
Gudmundsson E, Lam TB, Marconi L, Fernandéz-Pello S, Meijer RP, Volpe A,
Beisland C, Klatte T, Stewart GD, Bensalah K, Ljungberg B, Bertini R, Montorsi
F, Bex A, CAPITANIO U. Recurrence pattern in localized RCC: results from a
European multicenter database (RECUR). Urol Oncol. 2022
Nov;40(11):494.e11-494.e17. doi: 10.1016/j.urolonc.2022.08.007. Epub 2022 Sep
17. PMID: 36127233.
63: Fallara G, Bandini M, Larcher A, Pederzoli F, Karakiewicz P, Tian Z,
Briganti A, Necchi A, Salonia A, Bertini R, Montorsi F, Bex A, CAPITANIO U.
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant
VEGF-TKI Inhibitors? Curr Probl Cancer. 2021 Dec;45(6):100759. doi:
10.1016/j.currproblcancer.2021.100759. Epub 2021 Jun 5. PMID: 34130863.
64: Sharma G, Shah M, Ahluwalia P, Dasgupta P, Challacombe BJ, Bhandari M,
Ahlawat R, Rawal S, Buffi NM, Sivaraman A, Porter JR, Rogers C, Mottrie A, Abaza
R, Rha KH, Moon D, Yuvaraja TB, Parekh DJ, CAPITANIO U, Maes KK, Porpiglia F,
Turkeri L, Gautam G. Off-clamp Versus On-clamp Robot-assisted Partial
Nephrectomy: A Propensity-matched Analysis. Eur Urol Oncol. 2023 May
14:S2588-9311(23)00081-0. doi: 10.1016/j.euo.2023.04.005. Epub ahead of print.
PMID: 37193626.
65: Trevisani F, Larcher A, Cinque A, CAPITANIO U, Ripa F, Vago R, Bettiga A,
Benigni F, Carenzi C, Muttin F, Bertini R, Briganti A, Salonia A, Rampoldi L,
Montorsi F. The Association of Uromodulin Genotype with Renal Cancer
Aggressiveness. Eur Urol Focus. 2019 Mar;5(2):262-265. doi:
10.1016/j.euf.2017.04.009. Epub 2017 May 12. PMID: 28753889.
66: Nini A, Larcher A, Cazzaniga W, Dell'Oglio P, Cianflone F, Muttin F, Ripa F,
Salonia A, Briganti A, Montorsi F, Bertini R, CAPITANIO U. The side and the
location of the primary tumor does not affect the probability of lymph node
invasion in patients with renal cell carcinoma. World J Urol. 2019
Aug;37(8):1623-1629. doi: 10.1007/s00345-018-2573-3. Epub 2018 Nov 24. PMID:
30474699.
67: Antonelli A, Minervini A, Sandri M, Bertini R, Bertolo R, Carini M, Furlan
M, Larcher A, Mantica G, Mari A, Montorsi F, Palumbo C, Porpiglia F, Romagnani
P, Simeone C, Terrone C, CAPITANIO U. Below Safety Limits, Every Unit of
Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal
Function and Cancer-specific Mortality in Renal Cell Carcinoma. Eur Urol. 2018
Nov;74(5):661-667. doi: 10.1016/j.eururo.2018.07.029. Epub 2018 Aug 10. PMID:
30104082.
68: Carbonara U, Eun D, Derweesh I, CAPITANIO U, Celia A, Fiori C, Checcucci E,
Amparore D, Lee J, Larcher A, Patel D, Meagher M, Crocerossa F, Veccia A,
Hampton LJ, Montorsi F, Porpiglia F, Autorino R. Retroperitoneal versus
transepritoneal robot-assisted partial nephrectomy for postero-lateral renal
masses: an international multicenter analysis. World J Urol. 2021
Nov;39(11):4175-4182. doi: 10.1007/s00345-021-03741-2. Epub 2021 May 29. PMID:
34050813.
69: Hamilton ZA, CAPITANIO U, Lane BR, Larcher A, Yim K, Dey S, Cotta BH,
Meagher MF, Kirmiz S, Bezinque A, Eldefrawy A, Bradshaw A, Ryan S, Carenzi C,
Wan F, Proudfoot J, Montorsi F, Derweesh IH. Should partial nephrectomy be
considered "elective" in patients with stage 2 chronic kidney disease? A
comparative analysis of functional and survival outcomes after radical and
partial nephrectomy. World J Urol. 2019 Nov;37(11):2429-2437. doi:
10.1007/s00345-019-02650-9. Epub 2019 Feb 1. PMID: 30710156.
70: Crocerossa F, Fiori C, CAPITANIO U, Minervini A, Carbonara U, Pandolfo SD,
Loizzo D, Eun DD, Larcher A, Mari A, Grosso AA, Di Maida F, Hampton LJ,
Cantiello F, Damiano R, Porpiglia F, Autorino R. Estimated Glomerular Filtration
Rate Decline at 1 Year After Minimally Invasive Partial Nephrectomy: A
Multimodel Comparison of Predictors. Eur Urol Open Sci. 2022 Mar 3;38:52-59.
doi: 10.1016/j.euros.2022.02.005. PMID: 35495283; PMCID: PMC9051959.
71: Khene ZE, Larcher A, Bernhard JC, Doumerc N, Ouzaid I, CAPITANIO U, Nouhaud
FX, Boissier R, Rioux-Leclercq N, De La Taille A, Barthelemy P, Montorsi F,
Rouprêt M, Bigot P, Bensalah K; French Committee of Urologic Oncology. External
Validation of the ASSURE Model for Predicting Oncological Outcomes After
Resection of High-risk Renal Cell Carcinoma (RESCUE Study: UroCCR 88). Eur Urol
Open Sci. 2021 Oct 5;33:89-93. doi: 10.1016/j.euros.2021.09.004. PMID: 34661173;
PMCID: PMC8502703.
72: Antonelli A, Minervini A, CAPITANIO U. Editorial Comment. J Urol. 2019
Jun;201(6):1096. doi: 10.1097/01.JU.0000554374.17721.d6. PMID: 30816836.
73: Martini A, Fallara G, Pellegrino AA, Nocera L, Larcher A, Raggi D, Campi R,
Ploussard G, Malavaud B, Montorsi F, Pal SK, Spiess PE, Choueiri TK, Necchi A,
CAPITANIO U. Multidisciplinary team referral at diagnosis for patients with non-
metastatic renal cell carcinoma. Urol Oncol. 2022 Aug;40(8):384.e9-384.e14. doi:
10.1016/j.urolonc.2022.05.004. Epub 2022 Jun 3. PMID: 35667983.
74: Veccia A, Falagario U, Martini A, Marchioni M, Antonelli A, Simeone C,
Cormio L, CAPITANIO U, Mir MC, Derweesh I, Van Poppel H, Porpiglia F, Autorino
R. Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for
cT1 Renal Tumors: A Systematic Review and Meta-analysis of Outcomes and
Predictive Factors. Eur Urol Focus. 2021 May;7(3):574-581. doi:
10.1016/j.euf.2020.05.013. Epub 2020 Jun 19. PMID: 32571744.
75: Tafuri A, Sandri M, Martini A, CAPITANIO U, Mantica G, Terrone C, Furlan M,
Simeone C, Amparore D, Porpiglia F, Minervini A, Mari A, Cerruto MA, Antonelli
A. External validation of the Palacios' equation: a simple and accurate tool to
estimate the new baseline renal function after renal cancer surgery. World J
Urol. 2022 Feb;40(2):467-473. doi: 10.1007/s00345-021-03887-z. Epub 2021 Nov 26.
PMID: 34825945.
76: Sorce G, Hoeh B, Hohenhorst L, Panunzio A, Tappero S, Tian Z, Larcher A,
CAPITANIO U, Tilki D, Terrone C, Chun FKH, Antonelli A, Saad F, Shariat SF,
Montorsi F, Briganti A, Karakiewicz PI. Other-cause mortality and access to care
in metastatic renal cell carcinoma according to race/ethnicity. Urol Oncol. 2022
Nov;40(11):493.e9-493.e16. doi: 10.1016/j.urolonc.2022.06.022. Epub 2022 Jul 27.
PMID: 35907705.
77: Larcher A, Fallara G, Rosiello G, Re C, Baiamonte G, Agnesi S, Cignoli D,
Colandrea G, Basile G, Briganti A, Salonia A, Bertini R, Montorsi F, Capitanio
U. Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms:
Implications for Renal Cell Carcinoma Guidelines. Eur Urol. 2020
Sep;78(3):321-326. doi: 10.1016/j.eururo.2020.05.014. Epub 2020 Jun 2. PMID:
32507335.
78: Rosiello G, Piazza P, Puliatti S, Mazzone E, Amato M, Tames V, Farinha R, De
Groote R, Berquin C, Develtere D, Sinatti C, Larcher A, CAPITANIO U, D'Hondt F,
Schatteman P, Briganti A, Montorsi F, De Naeyer G, Mottrie A. Simplified PADUA
renal (SPARE) nephrometry score validation and long-term outcomes after robot-
assisted partial nephrectomy. Urol Oncol. 2022 Feb;40(2):65.e1-65.e9. doi:
10.1016/j.urolonc.2021.09.021. Epub 2021 Nov 22. PMID: 34824015.
79: Carbonara U, Simone G, Minervini A, Sundaram CP, Larcher A, Lee J, Checcucci
E, Fiori C, Patel D, Meagher M, Crocerossa F, Veccia A, Hampton LJ, Ditonno P,
Battaglia M, Brassetti A, Bove A, Mari A, Campi R, Carini M, Sulek J, Montorsi
F, CAPITANIO U, Eun D, Porpiglia F, Derweesh I, Autorino R. Robotic-assisted
Partial Nephrectomy for "Very Small" (<2 cm) Renal Mass: Results of a
Multicenter Contemporary Cohort. Eur Urol Focus. 2021 Sep;7(5):1115-1120. doi:
10.1016/j.euf.2020.10.001. Epub 2020 Nov 3. PMID: 33153954.
80: Cignoli D, Basile G, Fallara G, Rosiello G, Belladelli F, Cei F, Musso G, Re
C, Bertini R, Karakiewicz P, Mottrie A, Dehò F, Gallina A, Montorsi F, Salonia
A, CAPITANIO U, Larcher A. Risks and benefits of partial nephrectomy performed
with limited or with zero ischaemia time. BJU Int. 2023 Sep;132(3):283-290. doi:
10.1111/bju.16009. Epub 2023 Apr 4. PMID: 36932928.
81: Cianflone F, Lazarevic D, Palmisano A, Fallara G, Larcher A, Freschi M,
Dell'Antonio G, Scotti GM, Morelli MJ, Ferrara AM, Trevisani F, Cinque A,
Esposito A, Briganti A, Tacchetti C, Doglioni C, Del Maschio A, de Cobelli F,
Bertini R, Salonia A, Montorsi F, Tonon G, CAPITANIO U. Radiomic and gEnomic
approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a
translational pilot methodological study. Transl Androl Urol. 2022
Feb;11(2):149-158. doi: 10.21037/tau-21-713. PMID: 35280651; PMCID: PMC8899146.
82: Minervini A, Campi R, Lane BR, De Cobelli O, Sanguedolce F,
Hatzichristodoulou G, Antonelli A, Noyes S, Mari A, Rodriguez-Faba O, Keeley FX,
Langenhuijsen J, Musi G, Klatte T, Roscigno M, Akdogan B, Furlan M, Karakoyunlu
N, Marszalek M, CAPITANIO U, Volpe A, Brookman-May S, Gschwend JE, Smaldone MC,
Uzzo RG, Carini M, Kutikov A. Impact of Resection Technique on Perioperative
Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal
Masses: A Prospective Multicenter Study. J Urol. 2020 Mar;203(3):496-504. doi:
10.1097/JU.0000000000000591. Epub 2019 Oct 14. Erratum in: J Urol. 2021
Apr;205(4):1237. PMID: 31609167.
83: Benamran D, Albiges L, Bex A, Giannarini G, CAPITANIO U, Rouprêt M; EAU
Section of Oncological Urology (ESOU) Board. Treatment Options for De Novo
Metastatic Clear-cell Renal Cell Carcinoma: Current Recommendations and Future
Insights. Eur Urol Oncol. 2022 Feb;5(1):125-133. doi: 10.1016/j.euo.2021.08.003.
Epub 2021 Sep 14. PMID: 34531172.
84: DI Trapani E, Dell'oglio P, Larcher A, Nini A, Muttin F, Cianflone F, Dehò
F, Matloob R, DI Trapani D, Freschi M, Salonia A, Briganti A, Montorsi F,
Bertini R, CAPITANIO U. Pathological High-risk Renal Cell Carcinoma: Trends in
Clinical Characteristics Over 25 Years. Anticancer Res. 2018
Jul;38(7):4123-4130. doi: 10.21873/anticanres.12703. PMID: 29970539.
85: De Cobelli F, Papa M, Panzeri M, Colombo M, Steidler S, Ambrosi A, Cao R,
Gusmini S, Marra P, CAPITANIO U, Bertini R, Venturini M, Losa A, Gaboardi F,
Montorsi F, Cardone G. Percutaneous Microwave Ablation Versus Cryoablation in
the Treatment of T1a Renal Tumors. Cardiovasc Intervent Radiol. 2020
Jan;43(1):76-83. doi: 10.1007/s00270-019-02313-7. Epub 2019 Aug 26. PMID:
31451888.
86: Tan JS, Sathianathen N, Cumberbatch M, Dasgupta P, Mottrie A, Abaza R, Ho
Rha K, Yuvaraja TB, Parekh DJ, CAPITANIO U, Ahlawat R, Rawal S, Buffi NM,
Sivaraman A, Maes KK, Gautam G, Porpiglia F, Turkeri L, Bhandari M, Challacombe
B, Roscoe Porter J, Rogers CR, Moon DA. Outcomes in robot-assisted partial
nephrectomy for imperative vs elective indications. BJU Int. 2021 Dec;128 Suppl
3:30-35. doi: 10.1111/bju.15581. Epub 2021 Oct 6. PMID: 34448346.
87: Roussel E, Tasso G, Campi R, Kriegmair MC, Kara Ö, Klatte T, CAPITANIO U,
Bertolo R, Ingels A, Erdem S, Baekelandt L, Mir MC, Ouzaid I, Pavan N,
Beuselinck B, Gacci M, Minervini A, Volpe A, Albersen M; Young Academic
Urologists (YAU) Renal Cancer Working Group. Surgical Management and Outcomes of
Renal Tumors Arising from Horseshoe Kidneys: Results from an International
Multicenter Collaboration. Eur Urol. 2021 Jan;79(1):133-140. doi:
10.1016/j.eururo.2020.09.012. Epub 2020 Sep 16. PMID: 32950296.
88: Abdel Raheem A, Alowidah I, CAPITANIO U, Montorsi F, Larcher A, Derweesh I,
Ghali F, Mottrie A, Mazzone E, DE Naeyer G, Campi R, Sessa F, Carini M,
Minervini A, Raman JD, Rjepaj CJ, Kriegmair MC, Autorino R, Veccia A, Mir MC,
Claps F, Choi YD, Ham WS, Tadifa JP, Santok GD, Furlan M, Simeone C, Bada M,
Celia A, Carrión DM, Aguilera Bazan A, Ballesteros Ruiz C, Malki M, Barber N,
Hussain M, Micali S, Puliatti S, Alwahabi A, Alqahtani A, Rumaih A, Ghaith A,
Ghoneem AM, Hagras A, Eissa A, Alenzi MJ, Pavan N, Traunero F, Antonelli A,
Porcaro AB, Illiano E, Costantini E, Rha KH. Warm ischemia time length during
on-clamp partial nephrectomy: does it really matter? Minerva Urol Nephrol. 2022
Apr;74(2):194-202. doi: 10.23736/S2724-6051.21.04466-9. Epub 2021 Jul 26. PMID:
34308610.
89: CAPITANIO U, Larcher A, Fallara G, Trevisani F, Porrini E, Di Marco F,
Baiamonte G, Re C, Bettiga A, Dell'Antonio G, Doglioni C, De Cobelli F, Bertini
R, Salonia A, Montorsi F. Parenchymal biopsy in the management of patients with
renal cancer. World J Urol. 2021 Aug;39(8):2961-2968. doi:
10.1007/s00345-020-03572-7. Epub 2021 Jan 1. PMID: 33385247.
90: Teoh JY, Ng CF, Eto M, Chiruvella M, CAPITANIO U, Esen T, Zeng G,
Lechevallier E, Andonian S, de la Rosette J. Radical nephroureterectomy for UTUC
conferred survival benefits irrespective of age and comorbidities. World J Urol.
2022 Nov;40(11):2657-2665. doi: 10.1007/s00345-022-04152-7. Epub 2022 Sep 20.
PMID: 36125506.
91: Seisen T, Nison L, Remzi M, Klatte T, Mathieu R, Lucca I, Bozzini G,
CAPITANIO U, Novara G, Cussenot O, Compérat E, Renard-Penna R, Peyronnet B,
Merseburger AS, Fritsche HM, Hora M, Shariat SF, Colin P, Rouprêt M. Oncologic
Outcomes of Kidney Sparing Surgery versus Radical Nephroureterectomy for the
Elective Treatment of Clinically Organ Confined Upper Tract Urothelial Carcinoma
of the Distal Ureter. J Urol. 2016 May;195(5):1354-1361. doi:
10.1016/j.juro.2015.11.036. Epub 2015 Nov 21. PMID: 26612196.
92: Trevisani F, Di Marco F, Raggi D, Bettiga A, Vago R, Larcher A, Cinque A,
Salonia A, Briganti A, CAPITANIO U, Necchi A, Montorsi F. Renal function
outcomes in patients with muscle-invasive bladder cancer treated with
neoadjuvant pembrolizumab and radical cystectomy in the PURE-01 study. Int J
Cancer. 2021 Jul 1;149(1):186-190. doi: 10.1002/ijc.33554. Epub 2021 Mar 26.
PMID: 33720424.
93: CAPITANIO U, Rosiello G, Necchi A, Montorsi F, Larcher A. Predicting the
Risk of Progression in Patients With Kidney Cancer: Aiming at the Optimal Tool
in the Optimal Setting. J Clin Oncol. 2023 Jan 20;41(3):703. doi:
10.1200/JCO.22.00680. Epub 2022 Sep 27. PMID: 36166725.
94: CAPITANIO U, Pepe G, Incerti E, Larcher A, Trevisani F, Lucianò R, Mapelli
P, Bettinardi V, Monterisi C, Necchi A, Cascinu S, Bernardi R, Bertini R,
Doglioni C, Gianolli L, Salonia A, Picchio M, Montorsi F. The role of 18F-FAZA
PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a
prospective pilot trial. Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):554-560.
doi: 10.1007/s00259-020-04936-2. Epub 2020 Jul 8. PMID: 32638098.
95: Rosiello G, Knipper S, Palumbo C, Dzyuba-Negrean C, Pecoraro A, Mazzone E,
Mistretta FA, Tian Z, CAPITANIO U, Montorsi F, Shariat SF, Saad F, Briganti A,
Karakiewicz PI. Unmarried status is a barrier for access to treatment in
patients with metastatic renal cell carcinoma. Int Urol Nephrol. 2019
Dec;51(12):2181-2188. doi: 10.1007/s11255-019-02266-3. Epub 2019 Aug 29. PMID:
31468289.
96: Sorce G, Hoeh B, Hohenhorst L, Panunzio A, Tappero S, Tian Z, Kokorovic A,
Larcher A, CAPITANIO U, Tilki D, Terrone C, Chun FKH, Antonelli A, Saad F,
Shariat SF, Montorsi F, Briganti A, Karakiewicz PI. Cancer-specific Mortality in
T1a Renal Cell Carcinoma Treated with Local Tumor Destruction Versus Partial
Nephrectomy. Eur Urol Focus. 2023 Jan;9(1):125-132. doi:
10.1016/j.euf.2022.07.005. Epub 2022 Jul 30. PMID: 35918270.
97: Larcher A, De Naeyer G, Turri F, Dell'Oglio P, CAPITANIO U, Collins JW,
Wiklund P, Van Der Poel H, Montorsi F, Mottrie A; ERUS Educational Working Group
and the Young Academic Urologist Working Group on Robot-assisted Surgery. The
ERUS Curriculum for Robot-assisted Partial Nephrectomy: Structure Definition and
Pilot Clinical Validation. Eur Urol. 2019 Jun;75(6):1023-1031. doi:
10.1016/j.eururo.2019.02.031. Epub 2019 Apr 9. PMID: 30979635.
98: Mari A, Tellini R, Porpiglia F, Antonelli A, Schiavina R, Amparore D,
Bertini R, Brunocilla E, CAPITANIO U, Checcucci E, Da Pozzo L, Di Maida F, Fiori
C, Francavilla S, Furlan M, Gontero P, Longo N, Roscigno M, Simeone C,
Siracusano S, Ficarra V, Carini M, Minervini A. Perioperative and Mid-term
Oncological and Functional Outcomes After Partial Nephrectomy for Complex (PADUA
Score ≥10) Renal Tumors: A Prospective Multicenter Observational Study (the
RECORD2 Project). Eur Urol Focus. 2021 Nov;7(6):1371-1379. doi:
10.1016/j.euf.2020.07.004. Epub 2020 Aug 15. PMID: 32811779.
99: Capogrosso P, Larcher A, Sjoberg DD, Vertosick EA, Cianflone F, Dell'Oglio
P, Carenzi C, Salonia A, Vickers AJ, Montorsi F, Bertini R, CAPITANIO U. Risk
Based Surveillance after Surgical Treatment of Renal Cell Carcinoma. J Urol.
2018 Jul;200(1):61-67. doi: 10.1016/j.juro.2018.01.072. Epub 2018 Jan 31. PMID:
29371091; PMCID: PMC6699773.
100: Veccia A, Autorino R, Mir MC, Derweesh I, CAPITANIO U, Porpiglia F,
Antonelli A; RESURGE (REnal SURgery in Elderly) Group. Renal surgery for the
older population: time for a paradigm shift? Data from the RESURGE project.
Aging Clin Exp Res. 2020 Jan;32(1):173-178. doi: 10.1007/s40520-019-01366-5.
Epub 2019 Oct 10. PMID: 31602566.
101: Ouzaid I, CAPITANIO U, Staehler M, Wood CG, Leibovich BC, Ljungberg B, Van
Poppel H, Bensalah K; Young Academic Urologists Kidney Cancer Working Group of
the European Association of Urology. Surgical Metastasectomy in Renal Cell
Carcinoma: A Systematic Review. Eur Urol Oncol. 2019 Mar;2(2):141-149. doi:
10.1016/j.euo.2018.08.028. Epub 2018 Sep 24. PMID: 31017089.
102: CAPITANIO U, Stewart GD, Klatte T, Akdogan B, Roscigno M, Marszalek M,
Dell'Oglio P, Zaffuto E, Rodriguez Faba O, Salagierski M, Lingard J, Carini M,
Ouzaid I, Mir MC, Montorsi F, Da Pozzo LF, Stief C, Minervini A, Brookman-May
SD. Does the Unexpected Presence of Non-organ-confined Disease at Final
Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell
Carcinoma Who Underwent Partial Nephrectomy? Eur Urol Focus. 2018
Dec;4(6):972-977. doi: 10.1016/j.euf.2017.02.020. Epub 2017 Mar 21. PMID:
28753867.
103: Larcher A, Muttin F, Fossati N, Dell'Oglio P, Di Trapani E, Stabile A, Ripa
F, Trevisani F, Carenzi C, Picchio M, Briganti A, Salonia A, Mottrie A, Bertini
R, Montorsi F, CAPITANIO U. When to Perform Preoperative Bone Scintigraphy for
Kidney Cancer Staging: Indications for Preoperative Bone Scintigraphy. Urology.
2017 Dec;110:114-120. doi: 10.1016/j.urology.2017.08.043. Epub 2017 Sep 7. PMID:
28890151.
104: Hora M, Albiges L, Bedke J, Campi R, CAPITANIO U, Giles RH, Ljungberg B,
Marconi L, Klatte T, Volpe A, Abu-Ghanem Y, Dabestani S, Fernández-Pello S,
Hofmann F, Kuusk T, Tahbaz R, Powles T, Bex A, Trpkov K. European Association of
Urology Guidelines Panel on Renal Cell Carcinoma Update on the New World Health
Organization Classification of Kidney Tumours 2022: The Urologist's Point of
View. Eur Urol. 2023 Feb;83(2):97-100. doi: 10.1016/j.eururo.2022.11.001. Epub
2022 Nov 23. PMID: 36435661.
105: Erdem S, CAPITANIO U, Campi R, Mir MC, Roussel E, Pavan N, Kara O, Klatte
T, Kriegmair MC, Degirmenci E, Aydin R, Minervini A, Serni S, Berni A, Rebez G,
Ozcan F; European Association of Urology (EAU)-Young Academic Urologists (YAU)
Renal Cancer Working Group. External validation of the VENUSS prognostic model
to predict recurrence after surgery in non-metastatic papillary renal cell
carcinoma: A multi-institutional analysis. Urol Oncol. 2022
May;40(5):198.e9-198.e17. doi: 10.1016/j.urolonc.2022.01.006. Epub 2022 Feb 13.
PMID: 35172939.
106: Abu-Ghanem Y, Powles T, CAPITANIO U, Beisland C, Järvinen P, Stewart GD,
Gudmundsson E, Lam TBL, Marconi L, Fernandéz-Pello S, Nisen H, Meijer RP, Volpe
A, Ljungberg B, Klatte T, Bensalah K, Dabestani S, Bex A. Should patients with
low-risk renal cell carcinoma be followed differently after nephron-sparing
surgery vs radical nephrectomy? BJU Int. 2021 Sep;128(3):386-394. doi:
10.1111/bju.15415. Epub 2021 Apr 26. PMID: 33794055.
107: Larcher A, Muttin F, Peyronnet B, De Naeyer G, Khene ZE, Dell'Oglio P,
Ferreiro C, Schatteman P, CAPITANIO U, D'Hondt F, Montorsi F, Bensalah K,
Mottrie A. The Learning Curve for Robot-assisted Partial Nephrectomy: Impact of
Surgical Experience on Perioperative Outcomes. Eur Urol. 2019 Feb;75(2):253-256.
doi: 10.1016/j.eururo.2018.08.042. Epub 2018 Sep 19. PMID: 30243798.
108: Dell'Oglio P, Larcher A, Muttin F, Di Trapani E, Trevisani F, Ripa F,
Carenzi C, Briganti A, Salonia A, Montorsi F, Bertini R, CAPITANIO U. Lymph node
dissection should not be dismissed in case of localized renal cell carcinoma in
the presence of larger diseases. Urol Oncol. 2017 Nov;35(11):662.e9-662.e15.
doi: 10.1016/j.urolonc.2017.07.010. Epub 2017 Aug 8. PMID: 28801027.
109: Muttin F, Pecoraro A, Larcher A, Dell'Oglio P, Nini A, Cianflone F,
Trevisani F, Dehò F, Briganti A, Salonia A, Montorsi F, Bertini R, CAPITANIO U.
Predictive and prognostic effect of inflammatory lymphadenopathies in renal cell
carcinoma. World J Urol. 2019 Apr;37(4):701-708. doi: 10.1007/s00345-018-2412-6.
Epub 2018 Jul 25. PMID: 30046844.
110: Rosiello G, Larcher A, Fallara G, Giancristofaro C, Martini A, Re C, Cei F,
Musso G, Tian Z, Karakiewicz PI, Mottrie A, Bertini R, Salonia A, Necchi A,
Raggi D, Briganti A, Montorsi F, CAPITANIO U. Head-to-head comparison of all the
prognostic models recommended by the European Association of Urology Guidelines
to predict oncologic outcomes in patients with renal cell carcinoma. Urol Oncol.
2022 Jun;40(6):271.e19-271.e27. doi: 10.1016/j.urolonc.2021.12.010. Epub 2022
Feb 6. PMID: 35140049.
111: Sorce G, Hoeh B, Hohenhorst L, Panunzio A, Tappero S, Nimer N, Tian Z,
Larcher A, CAPITANIO U, Tilki D, Terrone C, Chun FKH, Antonelli A, Saad F,
Shariat SF, Montorsi F, Briganti A, Karakiewicz PI. Contemporary vs historical
survival rates in metastatic clear cell renal carcinoma according to
race/ethnicity. World J Urol. 2022 Dec;40(12):2971-2978. doi:
10.1007/s00345-022-04183-0. Epub 2022 Oct 12. PMID: 36222885.
112: Kuusk T, Klatte T, Zondervan P, Lagerveld B, Graafland N, Hendricksen K,
CAPITANIO U, Minervini A, Stewart GD, Ljungberg B, Horenblas S, Bex A. Outcome
after resection of occult and non-occult lymph node metastases at the time of
nephrectomy. World J Urol. 2021 Sep;39(9):3377-3383. doi:
10.1007/s00345-021-03633-5. Epub 2021 Feb 25. PMID: 33634323.
113: Sharma G, Shah M, Ahluwalia P, Dasgupta P, Challacombe BJ, Bhandari M,
Ahlawat R, Rawal S, Buffi NM, Sivaraman A, Porter JR, Rogers C, Mottrie A, Abaza
R, Rha KH, Moon D, Yuvaraja TB, Parekh DJ, CAPITANIO U, Maes KK, Porpiglia F,
Turkeri L, Gautam G. Development and Validation of a Nomogram Predicting
Intraoperative Adverse Events During Robot-assisted Partial Nephrectomy. Eur
Urol Focus. 2023 Mar;9(2):345-351. doi: 10.1016/j.euf.2022.09.004. Epub 2022 Sep
22. PMID: 36153228.
114: Nocera L, Stolzenbach LF, Ruvolo CC, Wenzel M, Tian Z, Rosiello G, Bravi
CA, Candela L, Basile G, Larcher A, Shariat SF, Bertini R, CAPITANIO U, Salonia
A, Montorsi F, Briganti A, Karakiewicz PI. Predicting the risk of pT3a stage in
cT1 clear cell renal cell carcinoma. Eur J Surg Oncol. 2021 May;47(5):1187-1190.
doi: 10.1016/j.ejso.2020.10.040. Epub 2020 Nov 5. PMID: 33168336.
115: Cignoli D, Fallara G, Aleotti F, Larcher A, Rosiello G, Rowe I, Basile G,
Colandrea G, Martini A, De Cobelli F, Brembilla G, Lucianò R, Colecchia M, Lena
MS, Partelli S, Tamburrino D, Zamboni G, Rubini C, Falconi M, Montorsi F,
Salonia A, CAPITANIO U. Pancreatic metastases after surgery for renal cell
carcinoma: survival and pathways of progression. World J Urol. 2022
Oct;40(10):2481-2488. doi: 10.1007/s00345-022-04106-z. Epub 2022 Jul 29. PMID:
35904571.
116: Sorce G, Hoeh B, Hohenhorst L, Panunzio A, Tappero S, Tian Z, Kokorovic A,
Larcher A, CAPITANIO U, Tilki D, Terrone C, Chun FKH, Antonelli A, Saad F,
Shariat SF, Montorsi F, Briganti A, Karakiewicz PI. Cancer-specific Mortality
After Cryoablation vs Heat-based Thermal Ablation in T1a Renal Cell Carcinoma. J
Urol. 2023 Jan;209(1):81-88. doi: 10.1097/JU.0000000000002984. Epub 2022 Nov 28.
PMID: 36440817.
117: Larcher A, Dell'Oglio P, Fossati N, Nini A, Muttin F, Suardi N, De Cobelli
F, Salonia A, Briganti A, Zhang X, Montorsi F, Bertini R, CAPITANIO U. When to
perform preoperative chest computed tomography for renal cancer staging. BJU
Int. 2017 Oct;120(4):490-496. doi: 10.1111/bju.13670. Epub 2016 Nov 2. PMID:
27684653.
118: Nini A, Larcher A, Cianflone F, Trevisani F, Terrone C, Volpe A, Regis F,
Briganti A, Salonia A, Montorsi F, Bertini R, CAPITANIO U. The Effect of
Anatomical Location of Lymph Node Metastases on Cancer Specific Survival in
Patients with Clear Cell Renal Cell Carcinoma. Front Surg. 2018 Mar 28;5:26.
doi: 10.3389/fsurg.2018.00026. PMID: 29740587; PMCID: PMC5931172.
119: Bedke J, Albiges L, CAPITANIO U, Giles RH, Hora M, Lam TB, Ljungberg B,
Marconi L, Klatte T, Volpe A, Abu-Ghanem Y, Dabestani S, Fernández-Pello S,
Hofmann F, Kuusk T, Tahbaz R, Powles T, Bex A. Updated European Association of
Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins
Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve
Metastatic Clear-Cell Renal Cell Carcinoma. Eur Urol. 2021 Mar;79(3):339-342.
doi: 10.1016/j.eururo.2020.12.005. Epub 2020 Dec 24. PMID: 33357997.
120: Carbonara U, Simone G, Minervini A, Sundaram CP, Larcher A, Lee J,
Checcucci E, Fiori C, Patel D, Meagher M, Crocerossa F, Veccia A, Hampton LJ,
Ditonno P, Battaglia M, Brassetti A, Bove A, Mari A, Campi R, Carini M, Sulek J,
Montorsi F, CAPITANIO U, Eun D, Porpiglia F, Derweesh I, Autorino R. Outcomes of
robot-assisted partial nephrectomy for completely endophytic renal tumors: A
multicenter analysis. Eur J Surg Oncol. 2021 May;47(5):1179-1186. doi:
10.1016/j.ejso.2020.08.012. Epub 2020 Aug 16. PMID: 32868149.
121: Simone G, CAPITANIO U, Tuderti G, Presicce F, Leonardo C, Ferriero M,
Misuraca L, Costantini M, Larcher A, Minisola F, Guaglianone S, Anceschi U,
Muttin F, Nini A, Trevisani F, Montorsi F, Bertini R, Gallucci M. On-clamp
versus off-clamp partial nephrectomy: Propensity score-matched comparison of
long-term functional outcomes. Int J Urol. 2019 Oct;26(10):985-991. doi:
10.1111/iju.14079. Epub 2019 Jul 24. PMID: 31342589.
122: Larcher A, Wallis CJD, Pavan N, Porpiglia F, Takagi T, Tanabe K, Rha KH,
Raheem AA, Yang B, Zang C, Perdonà S, Quarto G, Maurer T, Amiel T, Schips L,
Castellucci R, Crivellaro S, Dobbs R, Baiamonte G, Celia A, De Concilio B,
Furlan M, Lima E, Linares E, Micali S, Amparore D, De Naeyer G, Trombetta C,
Hampton LJ, Tracey A, Bindayi A, Antonelli A, Derweesh I, Mir C, Montorsi F,
Mottrie A, Autorino R, CAPITANIO U. Outcomes of minimally invasive partial
nephrectomy among very elderly patients: report from the RESURGE collaborative
international database. Cent European J Urol. 2020;73(3):273-279. doi:
10.5173/ceju.2020.0179. Epub 2020 Sep 8. PMID: 33133653; PMCID: PMC7587491.
123: Bandini M, Smith A, Zaffuto E, Pompe RS, Marchioni M, CAPITANIO U, Chun FK,
Kapoor AB, Shariat SF, Montorsi F, Briganti A, Karakiewicz PI. Effect of
pathological high-risk features on cancer-specific mortality in non-metastatic
clear cell renal cell carcinoma: a tool for optimizing patient selection for
adjuvant therapy. World J Urol. 2018 Jan;36(1):51-57. doi:
10.1007/s00345-017-2093-6. Epub 2017 Oct 11. PMID: 29022072.
124: Martini A, Turri F, Barod R, Rocco B, CAPITANIO U, Briganti A, Montorsi F,
Mottrie A, Challacombe B, Lagerveld BW, Bensalah K, Abaza R, Badani KK, Mehrazin
R, Buscarini M, Larcher A; Junior ERUS/YAU Working Group on Robot-assisted
Surgery of the European Association of Urology. Salvage Robot-assisted Renal
Surgery for Local Recurrence After Surgical Resection or Renal Mass Ablation:
Classification, Techniques, and Clinical Outcomes. Eur Urol. 2021
Dec;80(6):730-737. doi: 10.1016/j.eururo.2021.04.003. Epub 2021 Jun 2. PMID:
34088520.
125: Abu-Ghanem Y, Powles T, CAPITANIO U, Beisland C, Järvinen P, Stewart GD,
Gudmundsson EO, Lam TB, Marconi L, Fernandéz-Pello S, Nisen H, Meijer RP, Volpe
A, Ljungberg B, Klatte T, Dabestani S, Bex A. The Impact of Histological Subtype
on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell
Carcinoma After Surgery-Results from RECUR Consortium. Eur Urol Oncol. 2021
Jun;4(3):473-482. doi: 10.1016/j.euo.2020.09.005. Epub 2020 Oct 24. PMID:
33109495.
126: Anceschi U, Brassetti A, Tuderti G, Consiglia Ferriero M, Minervini A, Mari
A, Grosso AA, Carini M, CAPITANIO U, Larcher A, Montorsi F, Autorino R, Veccia
A, Fiori C, Amparore D, Porpiglia F, Eun D, Lee J, Gallucci M, Simone G. Risk
factors for progression of chronic kidney disease after robotic partial
nephrectomy in elderly patients: results from a multi-institutional
collaborative series. Minerva Urol Nephrol. 2022 Aug;74(4):452-460. doi:
10.23736/S2724-6051.21.04469-4. Epub 2021 Jun 22. PMID: 34156202.
127: Dell'Oglio P, De Naeyer G, Xiangjun L, Hamilton Z, CAPITANIO U, Ripa F,
Cianflone F, Muttin F, Schatteman P, D'Hondt F, Ma X, Bindayi A, Zhang X,
Derweesh I, Mottrie A, Montorsi F, Larcher A; ERUS Educational Working Group and
the YAU working group on robot-assisted surgery. The Impact of Surgical Strategy
in Robot-assisted Partial Nephrectomy: Is It Beneficial to Treat Anterior
Tumours with Transperitoneal Access and Posterior Tumours with Retroperitoneal
Access? Eur Urol Oncol. 2021 Feb;4(1):112-116. doi: 10.1016/j.euo.2018.12.010.
Epub 2019 Jan 22. PMID: 31411997.
128: Anele UA, Marchioni M, Yang B, Simone G, Uzzo RG, Lau C, Mir MC, Capitanio
U, Porter J, Jacobsohn K, de Luyk N, Mari A, Chang K, Fiori C, Sulek J, Mottrie
A, White W, Perdona S, Quarto G, Bindayi A, Ashrafi A, Schips L, Berardinelli F,
Zhang C, Gallucci M, Ramirez-Backhaus M, Larcher A, Kilday P, Liao M,
Langenstroer P, Dasgupta P, Challacombe B, Kutikov A, Minervini A, Rha KH,
Sundaram CP, Hampton LJ, Porpiglia F, Aron M, Derweesh I, Autorino R. Robotic
versus laparoscopic radical nephrectomy: a large multi-institutional analysis
(ROSULA Collaborative Group). World J Urol. 2019 Nov;37(11):2439-2450. doi:
10.1007/s00345-019-02657-2. Epub 2019 Feb 7. PMID: 30734072.
129: Gontero P, Mari A, Marra G, Nazzani S, Allasia M, Antonelli A, Barale M,
Brunocilla E, CAPITANIO U, Di Maida F, Gallioli A, Longo N, Montorsi F,
Porpiglia F, Porreca A, Rocco B, Simeone C, Schiavina R, Tellini R, Terrone C,
Villari D, Ficarra V, Carini M, Minervini A. Is partial nephrectomy safe and
effective in the setting of frail comorbid patients affected by renal cell
carcinoma? Insights from the RECORD 2 multicentre prospective study. Urol Oncol.
2021 Jan;39(1):78.e17-78.e26. doi: 10.1016/j.urolonc.2020.09.022. Epub 2020 Oct
27. PMID: 33127300.
130: Rosiello G, Pecoraro A, Luzzago S, Deuker M, Stolzenbach LF, Tian Z,
Larcher A, CAPITANIO U, Montorsi F, Shariat SF, Kapoor A, Saad F, Briganti A,
Karakiewicz PI. Prognostic factors in patients with small renal masses: a
comparison between <2 vs. 2.1-4 cm renal cell carcinomas. Cancer Causes Control.
2021 Feb;32(2):119-126. doi: 10.1007/s10552-020-01364-3. Epub 2020 Nov 9. PMID:
33169306.
131: Campi R, Berni A, Amparore D, Bertolo R, CAPITANIO U, Carbonara U, Erdem S,
Ingels A, Kara O, Klatte T, Kriegmair M, Marchioni M, Minervini A, Mir MC,
Papalia R, Pavan N, Pecoraro A, Gomez Rivas J, Rivasi G, Roussel E, Ungar A,
Serni S, Esperto F; European Society of Residents in Urology (ESRU), EAU Young
Academic Urologists (YAU) Renal Cancer Group. Impact of frailty on perioperative
and oncologic outcomes in patients undergoing surgery or ablation for renal
cancer: a systematic review. Minerva Urol Nephrol. 2022 Apr;74(2):146-160. doi:
10.23736/S2724-6051.21.04583-3. Epub 2021 Oct 29. PMID: 34714036.
132: CAPITANIO U, Larcher A, Terrone C, Antonelli A, Volpe A, Fiori C, Furlan M,
Dehò F, Minervini A, Serni S, Porpiglia F, Trevisani F, Salonia A, Carini M,
Simeone C, Montorsi F, Bertini R. End-Stage Renal Disease After Renal Surgery in
Patients with Normal Preoperative Kidney Function: Balancing Surgical Strategy
and Individual Disorders at Baseline. Eur Urol. 2016 Oct;70(4):558-561. doi:
10.1016/j.eururo.2016.03.023. Epub 2016 Mar 25. PMID: 27021797.
133: Bravi CA, Larcher A, CAPITANIO U, Mari A, Antonelli A, Artibani W, Barale
M, Bertini R, Bove P, Brunocilla E, Da Pozzo L, Di Maida F, Fiori C, Gontero P,
Li Marzi V, Longo N, Mirone V, Montanari E, Porpiglia F, Schiavina R, Schips L,
Simeone C, Siracusano S, Terrone C, Trombetta C, Volpe A, Montorsi F, Ficarra V,
Carini M, Minervini A. Perioperative Outcomes of Open, Laparoscopic, and Robotic
Partial Nephrectomy: A Prospective Multicenter Observational Study (The RECORd 2
Project). Eur Urol Focus. 2021 Mar;7(2):390-396. doi: 10.1016/j.euf.2019.10.013.
Epub 2019 Nov 12. PMID: 31727523.
134: CAPITANIO U, Larcher A, Montorsi F. Cytoreductive nephrectomy is dead, long
live cytoreductive nephrectomy. BJU Int. 2019 Jul;124(1):6-7. doi:
10.1111/bju.14675. Epub 2019 Feb 3. PMID: 30656818.
135: Bertolo R, Campi R, Klatte T, Kriegmair MC, Mir MC, Ouzaid I, Salagierski
M, Bhayani S, Gill I, Kaouk J, CAPITANIO U; Young Academic Urologists (YAU)
Kidney Cancer working group of the European Urological Association (EAU). Suture
techniques during laparoscopic and robot-assisted partial nephrectomy: a
systematic review and quantitative synthesis of peri-operative outcomes. BJU
Int. 2019 Jun;123(6):923-946. doi: 10.1111/bju.14537. Epub 2018 Nov 19. PMID:
30216617.
136: Bhandari M, Nallabasannagari AR, Reddiboina M, Porter JR, Jeong W, Mottrie
A, Dasgupta P, Challacombe B, Abaza R, Rha KH, Parekh DJ, Ahlawat R, Capitanio
U, Yuvaraja TB, Rawal S, Moon DA, Buffi NM, Sivaraman A, Maes KK, Porpiglia F,
Gautam G, Turkeri L, Meyyazhgan KR, Patil P, Menon M, Rogers C. Predicting
intra-operative and postoperative consequential events using machine-learning
techniques in patients undergoing robot-assisted partial nephrectomy: a
Vattikuti Collective Quality Initiative database study. BJU Int. 2020
Sep;126(3):350-358. doi: 10.1111/bju.15087. Epub 2020 May 18. PMID: 32315504.
137: Rodriguez Faba O, Linares E, Tilki D, CAPITANIO U, Evans CP, Montorsi F,
Martínez-Salamanca JI, Libertino J, Gontero P, Palou J. Impact of Microscopic
Wall Invasion of the Renal Vein or Inferior Vena Cava on Cancer-specific
Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus: A Multi-
institutional Analysis from the International Renal Cell Carcinoma-Venous
Thrombus Consortium. Eur Urol Focus. 2018 Apr;4(3):435-441. doi:
10.1016/j.euf.2017.01.009. Epub 2017 Feb 9. PMID: 28753848.
138: Arora S, Heulitt G, Menon M, Jeong W, Ahlawat RK, CAPITANIO U, Moon DA,
Maes KK, Rawal S, Mottrie A, Bhandari M, Rogers CG, Porter JR. Retroperitoneal
vs Transperitoneal Robot-assisted Partial Nephrectomy: Comparison in a Multi-
institutional Setting. Urology. 2018 Oct;120:131-137. doi:
10.1016/j.urology.2018.06.026. Epub 2018 Jul 25. PMID: 30053396.
139: Campi R, Tellini R, Sessa F, Mari A, Cocci A, Greco F, Crestani A, Gomez
Rivas J, Fiori C, Lapini A, Gallucci M, CAPITANIO U, Roupret M, Abaza R, Carini
M, Serni S, Ficarra V, Porpiglia F, Esperto F, Minervini A; European Society of
Residents in Urology (ESRU). Techniques and outcomes of minimally-invasive
surgery for nonmetastatic renal cell carcinoma with inferior vena cava
thrombosis: a systematic review of the literature. Minerva Urol Nefrol. 2019
Aug;71(4):339-358. doi: 10.23736/S0393-2249.19.03396-4. Epub 2019 Apr 5. PMID:
30957477.
140: Patel SH, Uzzo RG, Larcher A, Peyronnet B, Lane BR, Pruthi D, Reddy M,
CAPITANIO U, Joshi S, Noyes S, Eldefrawy A, Ghali F, Meagher MF, Hamilton ZA,
Yim K, Nasseri R, Bradshaw AW, Dey S, Kirmiz S, Wan F, Liss MA, Bensalah K,
Montorsi F, Derweesh IH. Oncologic and Functional Outcomes of Radical and
Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A
Multi-institutional Analysis. Clin Genitourin Cancer. 2020 Dec;18(6):e723-e729.
doi: 10.1016/j.clgc.2020.05.002. Epub 2020 May 11. PMID: 32600941.
141: Rosiello G, Palumbo C, Knipper S, Pecoraro A, Luzzago S, St-Hilaire PA,
Tian Z, CAPITANIO U, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.
Comparison of survival outcomes in patients with metastatic papillary vs. clear-
cell renal cell carcinoma: a propensity-score analysis. World J Urol. 2021
Feb;39(2):461-472. doi: 10.1007/s00345-020-03187-y. Epub 2020 Apr 6. PMID:
32253579.
142: Rieken M, Boorjian SA, Kluth LA, CAPITANIO U, Briganti A, Thompson RH,
Leibovich BC, Krabbe LM, Margulis V, Raman JD, Regelman M, Karakiewicz PI,
Rouprêt M, Abufaraj M, Foerster B, Gönen M, Shariat SF. Development and external
validation of a pathological nodal staging score for patients with clear cell
renal cell carcinoma. World J Urol. 2019 Aug;37(8):1631-1637. doi:
10.1007/s00345-018-2555-5. Epub 2018 Nov 7. PMID: 30406477; PMCID: PMC8389144.
143: Campi R, Di Maida F, Lane BR, De Cobelli O, Sanguedolce F,
Hatzichristodoulou G, Antonelli A, Noyes S, Mari A, Grosso AA, Rodriguez-Faba O,
Keeley FX, Langenhuijsen J, Musi G, Klatte T, Roscigno M, Akdogan B, Furlan M,
Karakoyunlu N, Marszalek M, CAPITANIO U, Volpe A, Brookman-May S, Gschwend JE,
Smaldone MC, Uzzo RG, Carini M, Kutikov A, Minervini A; Members of the SIB
International Consortium. Impact of surgical approach and resection technique on
the risk of Trifecta Failure after partial nephrectomy for highly complex renal
masses. Eur J Surg Oncol. 2022 Mar;48(3):687-693. doi:
10.1016/j.ejso.2021.11.126. Epub 2021 Nov 27. PMID: 34862095.
144: Rosiello G, Palumbo C, Knipper S, Pecoraro A, Luzzago S, Tian Z, Larcher A,
CAPITANIO U, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.
Histotype predicts the rate of lymph node invasion at nephrectomy in patients
with nonmetastatic renal cell carcinoma. Urol Oncol. 2020 May;38(5):537-544.
doi: 10.1016/j.urolonc.2020.01.013. Epub 2020 Feb 29. PMID: 32122729.
145: Marconi L, Kuusk T, CAPITANIO U, Beisland C, Lam T, Pello SF, Stewart GD,
Klatte T, Volpe A, Ljungberg B, Dabestani S, Bex A. Local Treatment of Recurrent
Renal Cell Carcinoma May Have a Significant Survival Effect Across All Risk-of-
recurrence Groups. Eur Urol Open Sci. 2022 Dec 15;47:65-72. doi:
10.1016/j.euros.2022.11.008. PMID: 36601038; PMCID: PMC9806698.
146: Pandolfo SD, Beksac AT, Derweesh I, Celia A, Schiavina R, Bianchi L, Costa
G, Carbonara U, Loizzo D, Lucarelli G, Cerrato C, Imbimbo C, Mirone V, Elbich J,
Basile G, Hampton LJ, Kim FJ, CAPITANIO U, Kaouk J, Autorino R. Percutaneous
Ablation <i>vs</i> Robot-Assisted Partial Nephrectomy for Completely Endophytic
Renal Masses: A Multicenter Trifecta Analysis with a Minimum 3-Year Follow-Up. J
Endourol. 2023 Mar;37(3):279-285. doi: 10.1089/end.2022.0478. Epub 2022 Nov 29.
PMID: 36367175.
147: Nientiedt M, Bertolo R, Campi R, CAPITANIO U, Erdem S, Kara Ö, Klatte T,
Larcher A, Mir MC, Ouzaid I, Roussel E, Salagierski M, Waldbillig F, Kriegmair
MC. Chronic Kidney Disease After Partial Nephrectomy in Patients With
Preoperative Inconspicuous Renal Function - Curiosity or Relevant Issue? Clin
Genitourin Cancer. 2020 Dec;18(6):e754-e761. doi: 10.1016/j.clgc.2020.05.007.
Epub 2020 May 20. PMID: 32660879.
148: Wagener N, Edelmann D, Benner A, Zigeuner R, Borgmann H, Wolff I, Krabbe
LM, Musquera M, Dell'Oglio P, CAPITANIO U, Klatte T, Cindolo L, May M, Brookman-
May SD; European Association of Urology (EAU) Young Academic Urologists (YAU)
Kidney Cancer Group. Outcome of papillary versus clear cell renal cell carcinoma
varies significantly in non-metastatic disease. PLoS One. 2017 Sep
21;12(9):e0184173. doi: 10.1371/journal.pone.0184173. PMID: 28934212; PMCID:
PMC5608215.
149: Rosiello G, Larcher A, Fallara G, Basile G, Cignoli D, Colandrea G, Re C,
Trevisani F, Karakiewicz PI, Salonia A, Bertini R, Briganti A, Montorsi F,
CAPITANIO U. The impact of intraoperative bleeding on the risk of chronic kidney
disease after nephron-sparing surgery. World J Urol. 2021 Jul;39(7):2553-2558.
doi: 10.1007/s00345-020-03504-5. Epub 2020 Oct 29. PMID: 33123741.
150: Campi R, Sessa F, Corti F, Carrion DM, Mari A, Amparore D, Mir MC, Fiori C,
Papalia R, Kutikov A, Volpe A, CAPITANIO U, Pierorazio PM, Scarpa RM, Porpiglia
F, Minervini A, Serni S, Esperto F; European Society of Residents in Urology
(ESRU) and the EAU Young Academic Urologists (YAU) Renal Cancer group. Triggers
for delayed intervention in patients with small renal masses undergoing active
surveillance: a systematic review. Minerva Urol Nefrol. 2020 Aug;72(4):389-407.
doi: 10.23736/S0393-2249.20.03870-9. PMID: 32734748.
151: Bertolo R, Autorino R, Simone G, Derweesh I, Garisto JD, Minervini A, Eun
D, Perdona S, Porter J, Rha KH, Mottrie A, White WM, Schips L, Yang B, Jacobsohn
K, Uzzo RG, Challacombe B, Ferro M, Sulek J, CAPITANIO U, Anele UA, Tuderti G,
Costantini M, Ryan S, Bindayi A, Mari A, Carini M, Keehn A, Quarto G, Liao M,
Chang K, Larcher A, De Naeyer G, De Cobelli O, Berardinelli F, Zhang C,
Langenstroer P, Kutikov A, Chen D, De Luyk N, Sundaram CP, Montorsi F, Stein RJ,
Haber GP, Hampton LJ, Dasgupta P, Gallucci M, Kaouk J, Porpiglia F. Outcomes of
Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter
Analysis (ROSULA Collaborative Group). Eur Urol. 2018 Aug;74(2):226-232. doi:
10.1016/j.eururo.2018.05.004. Epub 2018 May 19. PMID: 29784191.
152: Arora S, Chun B, Ahlawat RK, Abaza R, Adshead J, Porter JR, Challacombe B,
Dasgupta P, Gandaglia G, Moon DA, Yuvaraja TB, CAPITANIO U, Larcher A, Porpiglia
F, Mottrie A, Bhandari M, Rogers C. Conversion of Robot-assisted Partial
Nephrectomy to Radical Nephrectomy: A Prospective Multi-institutional Study.
Urology. 2018 Mar;113:85-90. doi: 10.1016/j.urology.2017.11.046. Epub 2017 Dec
25. PMID: 29284123.
153: Pecoraro A, Roussel E, Amparore D, Mari A, Grosso AA, Checcucci E, Montorsi
F, Larcher A, Van Poppel H, Porpiglia F, CAPITANIO U, Minervini A, Albersen M,
Serni S, Campi R. New-onset Chronic Kidney Disease After Surgery for Localised
Renal Masses in Patients with Two Kidneys and Preserved Renal Function: A
Contemporary Multicentre Study. Eur Urol Open Sci. 2023 May 5;52:100-108. doi:
10.1016/j.euros.2023.04.011. PMID: 37284048; PMCID: PMC10240519.
154: Bradshaw AW, Autorino R, Simone G, Yang B, Uzzo RG, Porpiglia F, Capitanio
U, Porter J, Bertolo R, Minervini A, Lau C, Jacobsohn K, Ashrafi A, Eun D,
Mottrie A, White WM, Schips L, Challacombe BJ, De Cobelli O, Mir CM, Veccia A,
Larcher A, Kutikov A, Aron M, Dasgupta P, Montorsi F, Gill IS, Sundaram CP,
Kaouk J, Derweesh IH. Robotic partial nephrectomy vs minimally invasive radical
nephrectomy for clinical T2a renal mass: a propensity score-matched comparison
from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group. BJU
Int. 2020 Jul;126(1):114-123. doi: 10.1111/bju.15064. Epub 2020 Jun 15. Erratum
in: BJU Int. 2021 Jun;127(6):748. PMID: 32232920.
155: Bindayi A, Autorino R, CAPITANIO U, Pavan N, Mir MC, Antonelli A, Takagi T,
Bertolo R, Maurer T, Ho Rha K, Long JA, Yang B, Schips L, Lima E, Breda A,
Linares E, Celia A, De Nunzio C, Dobbs R, Patel S, Hamilton Z, Tracey A, Larcher
A, Trombetta C, Palumbo C, Tanabe K, Amiel T, Raheem A, Fiard G, Zhang C,
Castellucci R, Palou J, Ryan S, Crivellaro S, Montorsi F, Porpiglia F, Derweesh
IH. Trifecta Outcomes of Partial Nephrectomy in Patients Over 75 Years Old:
Analysis of the REnal SURGery in Elderly (RESURGE) Group. Eur Urol Focus. 2020
Sep 15;6(5):982-990. doi: 10.1016/j.euf.2019.02.010. Epub 2019 Feb 22. PMID:
30799289.
156: Bedke J, Albiges L, CAPITANIO U, Giles RH, Hora M, Lam TB, Ljungberg B,
Marconi L, Klatte T, Volpe A, Abu-Ghanem Y, Dabestani S, Fernández-Pello S,
Hofmann F, Kuusk T, Tahbaz R, Powles T, Bex A. 2021 Updated European Association
of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell
Carcinoma. Eur Urol. 2022 Feb;81(2):134-137. doi: 10.1016/j.eururo.2021.11.022.
Epub 2021 Dec 15. PMID: 34920897.
157: Hamilton ZA, CAPITANIO U, Pruthi D, Ghali F, Larcher A, Patel DN, Eldefrawy
A, Patel S, Cotta BH, Bradshaw AW, Meagher MF, Miller NS, Carenzi C, Wan F, Liss
MA, McGregor T, Montorsi F, Derweesh IH. Risk Factors for Upstaging, Recurrence,
and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a
Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-
Metastasis Staging Criteria. Urology. 2020 Apr;138:60-68. doi:
10.1016/j.urology.2019.11.036. Epub 2019 Dec 11. PMID: 31836465.
158: Veccia A, Dell'oglio P, Antonelli A, Minervini A, Simone G, Challacombe B,
Perdonà S, Porter J, Zhang C, CAPITANIO U, Sundaram CP, Cacciamani G, Aron M,
Anele U, Hampton LJ, Simeone C, De Naeyer G, Bradshawh A, Mari A, Campi R,
Carini M, Fiori C, Gallucci M, Jacobsohn K, Eun D, Lau C, Kaouk J, Derweesh I,
Porpiglia F, Mottrie A, Autorino R. Robotic partial nephrectomy versus radical
nephrectomy in elderly patients with large renal masses. Minerva Urol Nefrol.
2020 Feb;72(1):99-108. doi: 10.23736/S0393-2249.19.03583-5. Epub 2019 Sep 13.
PMID: 31527571.
159: Antonelli A, Veccia A, Pavan N, Mir C, Breda A, Takagi T, Rha KH, Maurer T,
Zhang C, Long JA, De Nunzio C, Lima E, Ferro M, Micali S, Quarto G, Linares E,
Celia A, Schips L, Bove P, Larcher A, Fiori C, Mottrie A, Bindayi A, Trombetta
C, Silvestri T, Palou J, Faba OR, Tanabe K, Yang B, Fiard G, Tubaro A, Torres
JN, De Cobelli O, Bevilacqua L, Castellucci R, Tracey A, Hampton LJ, Montorsi F,
Perdonà S, Simeone C, Palumbo C, CAPITANIO U, Derweesh I, Porpiglia F, Autorino
R. Outcomes of Partial and Radical Nephrectomy in Octogenarians - A Multicenter
International Study (Resurge). Urology. 2019 Jul;129:139-145. doi:
10.1016/j.urology.2019.03.009. Epub 2019 Mar 23. PMID: 30914335.
160: Necchi A, Martini A, Raggi D, Cucchiara V, Colecchia M, Lucianò R, Villa L,
Mazzone E, Basile G, Scuderi S, Pederzoli F, Bandini M, Barletta F, Larcher A,
CAPITANIO U, Salonia A, Briganti A, Ross JS, Messina A, Montorsi F. A
feasibility study of preoperative pembrolizumab before radical
nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma:
PURE-02. Urol Oncol. 2022 Jan;40(1):10.e1-10.e6. doi:
10.1016/j.urolonc.2021.05.014. Epub 2021 Jun 17. PMID: 34147313.
161: Roussel E, Campi R, Larcher A, Verbiest A, Antonelli A, Palumbo C, Derweesh
I, Ghali F, Bradshaw A, Meagher MF, Heck M, Amiel T, Kriegmair MC, Rubio J,
Musquera M, D'Anna M, Autorino R, Guruli G, Veccia A, Linares-Espinos E, Van
Bruwaene S, Hevia V, Porpiglia F, Checcucci E, Minervini A, Mari A, Pavan N,
Claps F, Marchioni M, CAPITANIO U, Beuselinck B, Mir MC, Albersen M; Young
Academic Urologists Renal Cell Carcinoma Working Group. Rates and Predictors of
Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the
Registry for Metastatic Renal Cell Carcinoma. Eur Urol Oncol. 2020
Aug;3(4):523-529. doi: 10.1016/j.euo.2020.04.006. Epub 2020 May 12. PMID:
32414697.
162: Gershman B, Thompson RH, Boorjian SA, Larcher A, CAPITANIO U, Montorsi F,
Carenzi C, Bertini R, Briganti A, Lohse CM, Cheville JC, Leibovich BC. Radical
Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic
Renal Cell Carcinoma: A Multi-Institutional Analysis. J Urol. 2018
May;199(5):1143-1148. doi: 10.1016/j.juro.2017.11.114. Epub 2017 Dec 7. PMID:
29225056.
163: Klingler MJ, Babitz SK, Kutikov A, Campi R, Hatzichristodoulou G,
Sanguedolce F, Brookman-May S, Akdogan B, CAPITANIO U, Roscigno M, Volpe A,
Marszalek M, Uzzo RG, Antonelli A, Langenhuijsen J, Carini M, Minervini A, Lane
BR. Assessment of volume preservation performed before or after partial
nephrectomy accurately predicts postoperative renal function: Results from a
prospective multicenter study. Urol Oncol. 2019 Jan;37(1):33-39. doi:
10.1016/j.urolonc.2018.11.007. Epub 2018 Nov 23. PMID: 30473205.
164: Drusian L, Nigro EA, Mannella V, Pagliarini R, Pema M, Costa ASH, Benigni
F, Larcher A, Chiaravalli M, Gaude E, Montorsi F, CAPITANIO U, Musco G, Frezza
C, Boletta A. mTORC1 Upregulation Leads to Accumulation of the Oncometabolite
Fumarate in a Mouse Model of Renal Cell Carcinoma. Cell Rep. 2018 Jul
31;24(5):1093-1104.e6. doi: 10.1016/j.celrep.2018.06.106. PMID: 30067967.
165: Larcher A, CAPITANIO U, De Naeyer G, Fossati N, D'Hondt F, Muttin F, De
Groote R, Guazzoni G, Salonia A, Briganti A, Montorsi F, Mottrie A. Is Robot-
assisted Surgery Contraindicated in the Case of Partial Nephrectomy for Complex
Tumours or Relevant Comorbidities? A Comparative Analysis of Morbidity, Renal
Function, and Oncologic Outcomes. Eur Urol Oncol. 2018 May;1(1):61-68. doi:
10.1016/j.euo.2018.01.001. Epub 2018 May 15. PMID: 31100229.
166: Procopio G, Apollonio G, Cognetti F, Miceli R, Milella M, Mosca A, Chiuri
VE, Bearz A, Morelli F, Ortega C, Atzori F, Donini M, Ratta R, Raimondi A, Claps
M, Martinetti A, CAPITANIO U, de Braud FG, Cappelletti V, Verzoni E. Sorafenib
Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell
Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study. Eur Urol
Oncol. 2019 Nov;2(6):699-707. doi: 10.1016/j.euo.2019.08.011. Epub 2019 Sep 19.
PMID: 31542243.
167: Ouzaid I, Capogrosso P, Bertolo R, Bouvier A, Xylinas E, CAPITANIO U, Bigot
P. Off-clamp laparoscopic partial nephrectomy in a hybrid room after tumor
embolization versus conventional partial nephrectomy: A propensity score matched
pair analysis. Actas Urol Esp (Engl Ed). 2022 Nov;46(9):577-583. English,
Spanish. doi: 10.1016/j.acuroe.2022.03.004. Epub 2022 Mar 25. PMID: 35337767.
168: Larcher A, CAPITANIO U, Terrone C, Volpe A, De Angelis P, Dehó F, Fossati
N, Dell'Oglio P, Antonelli A, Furlan M, Simeone C, Serni S, Carini M, Minervini
A, Fiori C, Porpiglia F, Briganti A, Montorsi F, Bertini R. Elective Nephron
Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy
Only in Specific Subgroups of Patients with Renal Cell Carcinoma. J Urol. 2016
Oct;196(4):1008-13. doi: 10.1016/j.juro.2016.04.093. Epub 2016 May 25. PMID:
27235789.
169: Fichera D, Luciano R, Nini A, Freschi M, Doglioni C, Bertini R, Montorsi F,
CAPITANIO U. Clinical and pathological characteristics of a series of patients
with newly diagnosed primary renal liposarcoma: natural history and effect on
survival. Arch Esp Urol. 2018 Jul;71(6):555-558. English. PMID: 29991665.
170: Sharma G, Shah M, Ahluwalia P, Dasgupta P, Challacombe BJ, Bhandari M,
Ahlawat R, Rawal S, Buffi NM, Sivaraman A, Porter JR, Rogers C, Mottrie A, Abaza
R, Rha KH, Moon D, Yuvaraja TB, Parekh DJ, CAPITANIO U, Maes KK, Porpiglia F,
Turkeri L, Gautam G. Comparison of perioperative outcomes following
transperitoneal versus retroperitoneal robot-assisted partial nephrectomy: a
propensity-matched analysis of VCQI database. World J Urol. 2022
Sep;40(9):2283-2291. doi: 10.1007/s00345-022-04101-4. Epub 2022 Jul 22. PMID:
35867142.
171: Mari A, Tellini R, Antonelli A, Porpiglia F, Schiavina R, Amparore D,
Bertini R, Brunocilla E, CAPITANIO U, Checcucci E, Da Pozzo L, Di Maida F, Fiori
C, Furlan M, Gontero P, Longo N, Roscigno M, Simeone C, Siracusano S, Ficarra V,
Carini M, Minervini A. A Nomogram for the Prediction of Intermediate Significant
Renal Function Loss After Robot-assisted Partial Nephrectomy for Localized Renal
Tumors: A Prospective Multicenter Observational Study (RECORd2 Project). Eur
Urol Focus. 2022 Jul;8(4):980-987. doi: 10.1016/j.euf.2021.09.012. Epub 2021 Sep
21. PMID: 34561199.
172: Anceschi U, Ferriero MC, Tuderti G, Brassetti A, Bertolo R, CAPITANIO U,
Larcher A, Garisto J, Antonelli A, Mottrie A, Minervini A, Dell'Oglio P, Veccia
A, Amparore D, Mari A, Porpiglia F, Montorsi F, Kaouk J, Carini M, Autorino R,
Gallucci M, Simone G. Head to Head Impact of Margin, Ischemia, Complications,
Score Versus a Novel Trifecta Score on Oncologic and Functional Outcomes After
Robotic-assisted Partial Nephrectomy: Results of a Multicenter Series. Eur Urol
Focus. 2021 Nov;7(6):1391-1399. doi: 10.1016/j.euf.2020.06.021. Epub 2020 Jul
13. PMID: 32675046.
173: Antonelli A, Mari A, Tafuri A, Tellini R, CAPITANIO U, Gontero P, Grosso
AA, Li Marzi V, Longo N, Porpiglia F, Porreca A, Rocco B, Simeone C, Schiavina
R, Schips L, Siracusano S, Terrone C, Ficarra V, Carini M, Minervini A.
Prediction of significant renal function decline after open, laparoscopic, and
robotic partial nephrectomy: External validation of the Martini's nomogram on
the RECORD2 project cohort. Int J Urol. 2022 Jun;29(6):525-532. doi:
10.1111/iju.14831. Epub 2022 Mar 2. PMID: 35236009.
174: Marchioni M, Bandini M, Pompe RS, Martel T, Tian Z, Shariat SF, Kapoor A,
Cindolo L, Briganti A, Schips L, CAPITANIO U, Karakiewicz PI. The impact of
lymph node dissection and positive lymph nodes on cancer-specific mortality in
contemporary pT<sub>2-3</sub> non-metastatic renal cell carcinoma treated with
radical nephrectomy. BJU Int. 2018 Mar;121(3):383-392. doi: 10.1111/bju.14024.
Epub 2017 Oct 12. PMID: 28940649.
175: May M, Surcel C, CAPITANIO U, Dell'Oglio P, Klatte T, Shariat S, Ecke T,
Wolff I, Vergho D, Wagener N, Huck N, Pahernik S, Zastrow S, Wirth M, Borgmann
H, Haferkamp A, Musquera M, Krabbe LM, Herrmann E, Scavuzzo A, Mirvald C,
Hutterer G, Zigeuner R, Stief CG, Waidelich R, Cindolo L, Kalusova K, Brookman-
May SD; Collaborative Research On Renal Neoplasms Association (CORONA) and
European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney
Cancer Group. Prognostic and discriminative power of the 7th TNM classification
for patients with surgically treated papillary renal cell carcinoma: results of
a multi-institutional validation study (CORONA subtype project). Scand J Urol.
2017 Aug;51(4):269-276. doi: 10.1080/21681805.2017.1300187. Epub 2017 Apr 12.
PMID: 28399699.
176: Schiavina R, Mari A, Bianchi L, Amparore D, Antonelli A, Artibani W,
Brunocilla E, CAPITANIO U, Fiori C, Di Maida F, Gontero P, Larcher A, Li Marzi
V, Longo N, Marra G, Montanari E, Porpiglia F, Roscigno M, Simeone C, Siracusano
S, Tellini R, Terrone C, Villari D, Ficarra V, Carini M, Minervini A;
Collaborators. Predicting positive surgical margins in partial nephrectomy: A
prospective multicentre observational study (the RECORd 2 project). Eur J Surg
Oncol. 2020 Jul;46(7):1353-1359. doi: 10.1016/j.ejso.2020.01.022. Epub 2020 Jan
22. PMID: 32007380.
177: Hamilton ZA, Uzzo RG, Larcher A, Lane BR, Ristau B, CAPITANIO U, Ryan S,
Dey S, Correa A, Reddy M, Proudfoot JA, Nasseri R, Yim K, Noyes S, Bindayi A,
Montorsi F, Derweesh IH. Comparison of functional outcomes of robotic and open
partial nephrectomy in patients with pre-existing chronic kidney disease: a
multicenter study. World J Urol. 2018 Aug;36(8):1255-1262. doi:
10.1007/s00345-018-2261-3. Epub 2018 Mar 12. PMID: 29532222.
178: Fallara G, Larcher A, Rosiello G, Raggi D, Marandino L, Martini A, Basile
G, Colandrea G, Cignoli D, Belladelli F, Re C, Musso G, Cei F, Bertini R,
Briganti A, Salonia A, Montorsi F, Necchi A, CAPITANIO U. How to optimize the
use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit
the most? World J Urol. 2022 Nov;40(11):2667-2673. doi:
10.1007/s00345-022-04153-6. Epub 2022 Sep 20. PMID: 36125505.
179: Costantini M, Amoreo CA, Torregrossa L, Alì G, Munari E, Jeronimo C,
Henrique R, Petronilho S, CAPITANIO U, Lucianò R, Suardi N, Landi MT, Anceschi
U, Brassetti A, Fazio VM, Gallucci M, Simone G, Sentinelli S, Poeta ML.
Assessment of HER2 Protein Overexpression and Gene Amplification in Renal
Collecting Duct Carcinoma: Therapeutic Implication. Cancers (Basel). 2020 Nov
12;12(11):3345. doi: 10.3390/cancers12113345. PMID: 33198197; PMCID: PMC7697829.
180: Kuusk T, Zondervan P, Lagerveld B, Rosenzweig B, Raman A, Blok JM, de
Bruijn R, Graafland N, Hendricksen K, CAPITANIO U, Minervini A, Ljungberg B,
Horenblas S, Bex A. Topographic distribution of first landing sites of lymphatic
metastases from patients with renal cancer. Urol Oncol. 2020 May;38(5):521-525.
doi: 10.1016/j.urolonc.2019.12.023. Epub 2020 Mar 3. PMID: 32139289.
181: Marchioni M, Cheaib JG, Takagi T, Pavan N, Antonelli A, Everaerts W, Heck
M, Rha KH, Mottrie A, Kaouk J, CAPITANIO U, Lima E, Veccia A, Crivellaro S,
Linares E, Celia A, Porpiglia F, Autorino R, DI Nicola M, Schips L, Pierorazio
PM, Mir MC. Active surveillance for small renal masses in elderly patients does
not increase overall mortality rates compared to primary intervention: a
propensity score weighted analysis. Minerva Urol Nephrol. 2021
Dec;73(6):781-788. doi: 10.23736/S2724-6051.20.03785-6. Epub 2020 Sep 29. PMID:
32993273.
182: Mazzone E, Nazzani S, Preisser F, Tian Z, Marchioni M, Bandini M, Capitanio
U, Kapoor A, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, I Karakiewicz
P. Partial nephrectomy seems to confer a survival benefit relative to radical
nephrectomy in metastatic renal cell carcinoma. Cancer Epidemiol. 2018
Oct;56:118-125. doi: 10.1016/j.canep.2018.08.006. Epub 2018 Aug 30. PMID:
30173050.
183: Meagher MF, Lane BR, CAPITANIO U, Mehrazin R, Bradshaw AW, Noyes S, Larcher
A, Eldefrawy A, Ghali F, Patel D, Bruinius J, Dutt R, Keiner C, Miller N, Wan F,
Montorsi F, Derweesh IH. Comparison of renal functional outcomes of active
surveillance and partial nephrectomy in the management of oncocytoma. World J
Urol. 2021 Apr;39(4):1195-1201. doi: 10.1007/s00345-020-03299-5. Epub 2020 Jun
17. PMID: 32556559.
184: Porpiglia F, Mari A, Amparore D, Fiori C, Antonelli A, Artibani W, Bove P,
Brunocilla E, CAPITANIO U, Da Pozzo L, Di Maida F, Gontero P, Longo N, Marra G,
Rocco B, Schiavina R, Simeone C, Siracusano S, Tellini R, Terrone C, Villari D,
Ficarra V, Carini M, Minervini A; RECORD 2 Project. Transperitoneal vs
retroperitoneal minimally invasive partial nephrectomy: comparison of
perioperative outcomes and functional follow-up in a large multi-institutional
cohort (The RECORD 2 Project). Surg Endosc. 2021 Aug;35(8):4295-4304. doi:
10.1007/s00464-020-07919-4. Epub 2020 Aug 27. PMID: 32856156; PMCID: PMC8263535.
185: Tilki D, Chandrasekar T, CAPITANIO U, Ciancio G, Daneshmand S, Gontero P,
Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Linares Espinós E, Lorentz A,
Martinez-Salamanca JI, Master VA, McKiernan JM, Montorsi F, Novara G, Pahernik
S, Palou J, Pruthi RS, Rodriguez-Faba O, Russo P, Scherr DS, Shariat SF, Spahn
M, Terrone C, Vera-Donoso C, Zigeuner R, Libertino JA, Evans CP. Impact of lymph
node dissection at the time of radical nephrectomy with tumor thrombectomy on
oncological outcomes: Results from the International Renal Cell Carcinoma-Venous
Thrombus Consortium (IRCC-VTC). Urol Oncol. 2018 Feb;36(2):79.e11-79.e17. doi:
10.1016/j.urolonc.2017.10.008. Epub 2017 Nov 10. PMID: 29129353; PMCID:
PMC8404533.
186: Rieken M, Kluth LA, Fajkovic H, CAPITANIO U, Briganti A, Krabbe LM,
Margulis V, Abufaraj M, Mari A, Foerster B, Raman JD, Regelman M, Brookman-May
S, Sjoberg DD, Karakiewicz PI, Shariat SF. Predictors of Cancer-specific
Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The
Effect of Time to Recurrence. Clin Genitourin Cancer. 2018 Aug;16(4):e903-e908.
doi: 10.1016/j.clgc.2018.03.003. Epub 2018 Mar 24. PMID: 29653814.
187: Abdel Raheem A, Landi I, Alowidah I, CAPITANIO U, Montorsi F, Larcher A,
Derweesh I, Ghali F, Mottrie A, Mazzone E, De Naeyer G, Campi R, Sessa F, Carini
M, Minervini A, Raman JD, Rjepaj CJ, Kriegmair MC, Autorino R, Veccia A, Mir MC,
Claps F, Choi YD, Ham WS, Santok GD, Tadifa JP, Syling J, Furlan M, Simeone C,
Bada M, Celia A, Carrión DM, Aguilera Bazan A, Ruiz CB, Malki M, Barber N,
Hussain M, Micali S, Puliatti S, Ghaith A, Hagras A, Ghoneem AM, Eissa A,
Alqahtani A, Rumaih A, Alwahabi A, Alenzi MJ, Pavan N, Traunero F, Antonelli A,
Porcaro AB, Illiano E, Costantini E, Rha KH. External validation of yonsei
nomogram predicting chronic kidney disease development after partial
nephrectomy: An international, multicenter study. Int J Urol. 2023
Mar;30(3):308-317. doi: 10.1111/iju.15108. Epub 2022 Dec 7. PMID: 36478459.
188: Arora S, Bronkema C, Porter JR, Mottrie A, Dasgupta P, Challacombe B, Rha
KH, Ahlawat RK, CAPITANIO U, Yuvaraja TB, Rawal S, Moon DA, Sivaraman A, Maes
KK, Porpiglia F, Gautam G, Turkeri L, Bhandari M, Jeong W, Menon M, Rogers CG,
Abdollah F. Omission of Cortical Renorrhaphy During Robotic Partial Nephrectomy:
A Vattikuti Collective Quality Initiative Database Analysis. Urology. 2020
Dec;146:125-132. doi: 10.1016/j.urology.2020.09.003. Epub 2020 Sep 15. PMID:
32941944.
189: Arora S, Abaza R, Adshead JM, Ahlawat RK, Challacombe BJ, Dasgupta P,
Gandaglia G, Moon DA, Yuvaraja TB, CAPITANIO U, Larcher A, Porpiglia F, Porter
JR, Mottrie A, Bhandari M, Rogers C. 'Trifecta' outcomes of robot-assisted
partial nephrectomy in solitary kidney: a Vattikuti Collective Quality
Initiative (VCQI) database analysis. BJU Int. 2018 Jan;121(1):119-123. doi:
10.1111/bju.13967. Epub 2017 Aug 16. PMID: 28749068.
190: Rosiello G, Larcher A, Fallara G, Cignoli D, Re C, Martini A, Tian Z,
Karakiewicz PI, Mottrie A, Boarin M, Villa G, Trevisani F, Marandino L, Raggi D,
Necchi A, Bertini R, Salonia A, Briganti A, Montorsi F, CAPITANIO U. A
comprehensive assessment of frailty status on surgical, functional and oncologic
outcomes in patients treated with partial nephrectomy-A large, retrospective,
single-center study. Urol Oncol. 2023 Mar;41(3):149.e17-149.e25. doi:
10.1016/j.urolonc.2022.10.008. Epub 2022 Nov 9. PMID: 36369233.
191: CAPITANIO U, Stewart GD, Larcher A, Ouzaid I, Akdogan B, Roscigno M,
Marszalek M, Dell'Oglio P, Salagierski M, Volpe A, Mir MC, Kriegmair M, Terrone
C, Brookman-May SD, Montorsi F, Klatte T; Kidney Cancer Working Group of the
Young Academic Urologists (YAU) Working Party of the European Association of
Urology (EAU). European temporal trends in the use of lymph node dissection in
patients with renal cancer. Eur J Surg Oncol. 2017 Nov;43(11):2184-2192. doi:
10.1016/j.ejso.2017.07.016. Epub 2017 Aug 3. PMID: 28801061.
192: Mir MC, Pavan N, CAPITANIO U, Antonelli A, Derweesh I, Rodriguez-Faba O,
Linares E, Takagi T, Rha KH, Fiori C, Maurer T, Zang C, Mottrie A, Umari P, Long
JA, Fiard G, De Nunzio C, Tubaro A, Tracey AT, Ferro M, De Cobelli O, Micali S,
Bevilacqua L, Torres J, Schips L, Castellucci R, Dobbs R, Quarto G, Bove P,
Celia A, De Concilio B, Trombetta C, Silvestri T, Larcher A, Montorsi F, Palumbo
C, Furlan M, Bindayi A, Hamilton Z, Breda A, Palou J, Aguilera A, Tanabe K,
Raheem A, Amiel T, Yang B, Lima E, Crivellaro S, Perdona S, Gregorio C, Barbati
G, Porpiglia F, Autorino R. Partial versus radical nephrectomy in very elderly
patients: a propensity score analysis of surgical, functional and oncologic
outcomes (RESURGE project). World J Urol. 2020 Jan;38(1):151-158. doi:
10.1007/s00345-019-02665-2. Epub 2019 Apr 1. PMID: 30937569.
193: Cerrato C, Meagher MF, Autorino R, Simone G, Yang B, Uzzo RG, Kutikov A,
Porpiglia F, CAPITANIO U, Montorsi F, Porter J, Beksac AT, Puri D, Nguyen M,
Wang L, Hakimi K, Dhanji S, Liu F, Cerruto MA, Pandolfo SD, Minervini A, Lau C,
Monish A, Eun D, Mottrie A, Mir C, Sundaram C, Antonelli A, Kaouk J, Derweesh
IH. Partial versus radical nephrectomy for complex renal mass: multicenter
comparative analysis of functional outcomes (Rosula collaborative group).
Minerva Urol Nephrol. 2023 Aug;75(4):425-433. doi:
10.23736/S2724-6051.23.05123-6. PMID: 37530659.
194: Wolff I, Scavuzzo A, CAPITANIO U, Klatte T, Shariat SF, Wagener N, Zastrow
S, Borgmann H, Krabbe LM, Hutterer G, May M, Brookman-May SD; Collaborative
Research On Renal Neoplasms Association (CORONA) and the European Association of
Urology (EAU) Young Academic Urologists (YAU) Kidney Cancer Group. Organ
Preservation Is Less Frequently Performed in Women Surgically Treated for
Papillary Renal Cell Carcinoma-Results of a Comprehensive Multicenter Study.
Urology. 2017 Nov;109:107-114. doi: 10.1016/j.urology.2017.06.042. Epub 2017 Aug
9. PMID: 28802570.
195: Brassetti A, Anceschi U, Bertolo R, Ferriero M, Tuderti G, Costantini M,
CAPITANIO U, Larcher A, Antonelli A, Mottrie A, Minervini A, Dell'oglio P,
Veccia A, Amparore D, Flammia RS, Lombardo R, De Nunzio C, Benecchi L, Mari A,
Porpiglia F, Montorsi F, Kaouk J, Autorino R, Gallucci M, Simone G.
Comprehensive long-term assessment of outcomes following robot-assisted partial
nephrectomy for renal cell carcinoma: the ROMe's achievement and its predicting
nomogram. Minerva Urol Nefrol. 2020 Aug;72(4):482-489. doi:
10.23736/S0393-2249.20.03813-8. Epub 2020 Apr 16. PMID: 32298069.
196: Mari A, Campi R, Schiavina R, Amparore D, Antonelli A, Artibani W, Barale
M, Bertini R, Borghesi M, Bove P, Brunocilla E, CAPITANIO U, Da Pozzo L, Daja J,
Gontero P, Larcher A, Li Marzi V, Longo N, Mirone V, Montanari E, Pisano F,
Porpiglia F, Simeone C, Siracusano S, Tellini R, Trombetta C, Volpe A, Ficarra
V, Carini M, Minervini A; Collaborators. Nomogram for predicting the likelihood
of postoperative surgical complications in patients treated with partial
nephrectomy: a prospective multicentre observational study (the RECORd 2
project). BJU Int. 2019 Jul;124(1):93-102. doi: 10.1111/bju.14680. Epub 2019 Feb
12. PMID: 30653796.
197: Rosiello G, Scilipoti P, Larcher A, Fallara G, Colandrea G, Basile G, Re C,
Tian Z, Karakiewicz PI, Mottrie A, Trevisani F, Marandino L, Raggi D, Necchi A,
Bertini R, Salonia A, Briganti A, Montorsi F, CAPITANIO U. Neglected lymph nodal
metastases in patients with renal cancer: when to extend the anatomical template
of lymph node dissection during nephrectomy. World J Urol. 2023
Jun;41(6):1573-1579. doi: 10.1007/s00345-023-04413-z. Epub 2023 May 6. PMID:
37148324.
198: Pandolfo SD, Loizzo D, Beksac AT, Derweesh I, Celia A, Bianchi L, Elbich J,
Costa G, Carbonara U, Lucarelli G, Cerrato C, Meagher M, Ditonno P, Hampton LJ,
Basile G, Kim FJ, Schiavina R, CAPITANIO U, Kaouk J, Autorino R. Percutaneous
thermal ablation for cT1 renal mass in solitary kidney: A multicenter trifecta
comparative analysis versus robot-assisted partial nephrectomy. Eur J Surg
Oncol. 2023 Feb;49(2):486-490. doi: 10.1016/j.ejso.2022.09.022. Epub 2022 Oct 4.
PMID: 36216659.
199: Flammia RS, Anceschi U, Tufano A, Tuderti G, Ferriero MC, Brassetti A, Mari
A, Di Maida F, Minervini A, Derweesh IH, CAPITANIO U, Larcher A, Montorsi F, Eun
DD, Lee J, Luciani LG, Cai T, Malossini G, Veccia A, Autorino R, Fiori C,
Porpiglia F, Gallucci M, Leonardo C, Simone G. Is Hypertension Associated with
Worse Renal Functional Outcomes after Minimally Invasive Partial Nephrectomy?
Results from a Multi-Institutional Cohort. J Clin Med. 2022 Feb 25;11(5):1243.
doi: 10.3390/jcm11051243. PMID: 35268334; PMCID: PMC8911097.
200: Nandanan N, Veccia A, Antonelli A, Derweesh I, Mottrie A, Minervini A, Aron
M, Simone G, CAPITANIO U, Simeone C, Eun D, Perdonà S, Porter J, Sundaram C,
Zhang C, Uzzo R, Challacombe B, Hampton LJ, Kaouk J, Porpiglia F, Autorino R.
Outcomes and predictors of benign histology in patients undergoing robotic
partial or radical nephrectomy for renal masses: a multicenter study. Cent
European J Urol. 2020;73(1):33-38. doi: 10.5173/ceju.2020.0019. Epub 2020 Mar
23. PMID: 32395320; PMCID: PMC7203778.
201: Rosiello G, Larcher A, Montorsi F, CAPITANIO U. Reply to Sebastiano Buti
and Giulia Claire Giudice's Letter to the Editor comparing the prognostic models
to predict oncologic outcomes in patients with renal cell carcinoma: Is AUC
close enough to clinical practice? Urol Oncol. 2022 Apr
14:S1078-1439(22)00066-7. doi: 10.1016/j.urolonc.2022.02.015. Urol Oncol. 2022
Aug;40(8):386. doi: 10.1016/j.urolonc.2022.04.018. Epub 2022 May 27. PMID:
35644799.
202: CAPITANIO U, Terrone C, Antonelli A, Minervini A, Volpe A, Furlan M,
Matloob R, Regis F, Fiori C, Porpiglia F, Di Trapani E, Zacchero M, Serni S,
Salonia A, Carini M, Simeone C, Montorsi F, Bertini R. Nephron-sparing
techniques independently decrease the risk of cardiovascular events relative to
radical nephrectomy in patients with a T1a-T1b renal mass and normal
preoperative renal function. Eur Urol. 2015 Apr;67(4):683-9. doi:
10.1016/j.eururo.2014.09.027. Epub 2014 Oct 3. PMID: 25282367.
203: Ljungberg B, Bedke J, CAPITANIO U, Bex A. Reply to Yongbao Wei, Ruochen
Zhang, and Le Lin's Letter to the Editor re: Börje Ljungberg, Laurence Albiges,
Yasmin Abu-Ghanem, et al. European Association of Urology Guidelines on Renal
Cell Carcinoma: The 2022 Update. Eur Urol. 2022;82:e88. Eur Urol. 2022
Oct;82(4):e111-e112. doi: 10.1016/j.eururo.2022.06.008. Epub 2022 Jun 27. PMID:
35773149.
204: Cerrato C, Patel D, Autorino R, Simone G, Yang B, Uzzo R, Porpiglia F,
CAPITANIO U, Porter J, Beksac AT, Minervini A, Antonelli A, Cerruto MA, Lau C,
Ashrafi A, Eun D, Mottrie A, Mir C, Meagher MF, Puri D, Nguyen M, Dhanji S, Liu
F, Pandolfo SD, Kutikov A, Montorsi F, Gill IS, Sundaram C, Kaouk J, Derweesh
IH. Partial or radical nephrectomy for complex renal mass: a comparative
analysis of oncological outcomes and complications from the ROSULA (Robotic
Surgery for Large Renal Mass) Collaborative Group. World J Urol. 2023
Mar;41(3):747-755. doi: 10.1007/s00345-023-04279-1. Epub 2023 Mar 1. PMID:
36856832.
205: CAPITANIO U, Larcher A, Montorsi F. Re: Toni K. Choueiri, Piotr Tomczak, Se
Hoon Park, et al. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell
Carcinoma. N Engl J Med 2021;385:683-94: Adjuvant Pembrolizumab After
Nephrectomy: A Plea to Reconsider the Need for Lymph Node Dissection. Eur Urol.
2022 Jan;81(1):e28. doi: 10.1016/j.eururo.2021.09.034. Epub 2021 Nov 4. PMID:
34742588.
206: Buti S, Karakiewicz PI, Bersanelli M, CAPITANIO U, Tian Z, Cortellini A,
Taguchi S, Briganti A, Montorsi F, Leonardi F, Bandini M. Validation of the
GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology
and End Results (SEER) database: A new tool to predict survival in surgically
treated renal cell carcinoma patients. Sci Rep. 2019 Sep 13;9(1):13218. doi:
10.1038/s41598-019-49250-6. Erratum in: Sci Rep. 2020 Feb 5;10(1):2304. PMID:
31519981; PMCID: PMC6744465.
207: Bhindi B, Wallis CJD, Boorjian SA, Thompson RH, Farrell A, Kim SP, Karam
JA, CAPITANIO U, Golijanin D, Leibovich BC, Gershman B. The role of lymph node
dissection in the management of renal cell carcinoma: a systematic review and
meta-analysis. BJU Int. 2018 May;121(5):684-698. doi: 10.1111/bju.14127. Epub
2018 Mar 1. PMID: 29319926.
208: CAPITANIO U, Deho' F, Dell'Oglio P, Larcher A, Capogrosso P, Nini A,
Carenzi C, Freschi M, Briganti A, Salonia A, Montorsi F, Bertini R.
Lymphadenopathies in patients with renal cell carcinoma: clinical and
pathological predictors of pathologically confirmed lymph node invasion. World J
Urol. 2016 Aug;34(8):1139-45. doi: 10.1007/s00345-015-1747-5. Epub 2015 Dec 15.
PMID: 26670425.
209: Montorsi F, CAPITANIO U, Rosiello G, Larcher A. Re: Sarah P. Psutka, Roman
Gulati, Michael A.S. Jewett, et al. A Clinical Decision Aid to Support
Personalized Treatment Selection for Patients with Clinical T1 Renal Masses:
Results from a Multi-institutional Competing-risks Analysis. Eur Urol.
2022;81:576-85. Eur Urol. 2022 Jun;81(6):e149. doi:
10.1016/j.eururo.2022.02.026. Epub 2022 Mar 10. PMID: 35282969.
210: CAPITANIO U, Larcher A, Dell'Oglio P, Montorsi F, Bertini R. Reply from
Authors re: Steven C. Campbell, Wen Dong, Joe Zabell, Diego Aguilar Palacios.
End-stage Renal Disease After Renal Surgery: Partial Nephrectomy Is Protective,
but to What Degree and Consequence? Eur Urol 2016;70:562-3: Functional Outcomes
After Renal Surgery: It's Time to Change Our Point of View. Eur Urol. 2016
Oct;70(4):564-565. doi: 10.1016/j.eururo.2016.04.029. Epub 2016 May 4. PMID:
27156129.
211: Capogrosso P, Larcher A, Nini A, Muttin F, Cianflone F, Ripa F, Briganti A,
Necchi A, Montorsi F, Salonia A, Bertini R, CAPITANIO U. The critical role of
lymph node dissection in selecting high-risk nonmetastatic renal cancer
candidates for adjuvant therapy after nephrectomy. Urol Oncol. 2019
Apr;37(4):293.e25-293.e30. doi: 10.1016/j.urolonc.2019.01.009. Epub 2019 Jan 28.
PMID: 30704958.
212: Campi R, Grosso AA, Lane BR, DE Cobelli O, Sanguedolce F,
Hatzichristodoulou G, Antonelli A, Noyes S, DI Maida F, Mari A, Rodriguez-Faba
O, Keeley FX, Langenhuijsen J, Musi G, Klatte T, Roscigno M, Akdogan B, Furlan
M, Karakoyunlu N, Marszalek M, CAPITANIO U, Volpe A, Brookman-May S, Gschwend
JE, Smaldone MC, Uzzo RG, Kutikov A, Minervini A; SIB International Consortium.
Impact of Trifecta definition on rates and predictors of "successful" robotic
partial nephrectomy for localized renal masses: results from the Surface-
Intermediate-Base Margin Score International Consortium. Minerva Urol Nephrol.
2022 Apr;74(2):186-193. doi: 10.23736/S2724-6051.21.04601-2. PMID: 35345387.
213: CAPITANIO U, Freschi M, Rosiello G, Fallara G, Musso G, Cei F, Basile G,
Rowe I, Canibus D, Lucianò R, Doglioni C, Re C, Salonia A, Larcher A, Montorsi
F. Case of the Month from San Raffaele Hospital, Milan, Italy: paraneoplastic
presentation of small renal masses. BJU Int. 2023 Apr;131(4):434-436. doi:
10.1111/bju.15872. Epub 2022 Dec 5. PMID: 36468262.
214: Mager R, Daneshmand S, Evans CP, Palou J, Martínez-Salamanca JI, Master VA,
McKiernan JM, Libertino JA, Haferkamp A; International Renal Cell Carcinoma-
Venous Thrombus Consortium; Haferkamp A, CAPITANIO U, Carballido JA, Chantada V,
Chromecki T, Ciancio G, Daneshmand S, Evans CP, Gontero P, González J,
Hohenfellner M, Huang WC, Koppie TM, Libertino JA, Espinós EL, Lorentz A,
Martínez-Salamanca JI, Master VA, McKiernan JM, Montorsi F, Novara G, O'Malley
P, Pahernik S, Palou J, Moreno JL, Pruthi RS, Faba OR, Russo P, Scherr DS,
Shariat SF, Spahn M, Terrone C, Tilki D, Vázquez-Martul D, Donoso CV, Vergho D,
Wallen EM, Zigeuner R. Renal cell carcinoma with inferior vena cava involvement:
Prognostic effect of tumor thrombus consistency on cancer specific survival. J
Surg Oncol. 2016 Nov;114(6):764-768. doi: 10.1002/jso.24395. Epub 2016 Aug 26.
PMID: 27562252; PMCID: PMC5560037.
215: Bertolo R, CAPITANIO U; Kidney Cancer Working Group of the Young Academic
Urologists Working Party of the European Association of Urology. Re: Acute
Kidney Injury After Partial Nephrectomy in Solitary Kidneys: Impact on Long-term
Stability of Renal Function. Eur Urol. 2019 Feb;75(2):346-348. doi:
10.1016/j.eururo.2018.10.043. Epub 2018 Nov 8. PMID: 30415769.
216: Martini A, Falagario UG, Bravi CA, Abaza R, Eun DD, Bhandari A, Porter JR,
CAPITANIO U, Montorsi F, Hemal AK, Badani KK. Editorial Comment from Dr Martini
et al. to Independent external validation of a nomogram to define risk
categories for a significant decline in estimated glomerular filtration rate
after robotic-assisted partial nephrectomy. Int J Urol. 2021 Jan;28(1):80-81.
doi: 10.1111/iju.14437. Epub 2020 Nov 9. PMID: 33169453.
217: Zastrow S, Krabbe LM, Wolff I, CAPITANIO U, Klatte T, Ecke T, Huck N,
Borgmann H, Scavuzzo A, Cindolo L, Schips L, Surcel C, Mirvald C, Cabo AV,
Musquera M, Hutterer G, Prochazkova K, Stief C, Wirth M, May M, Brookman-May S.
External validation of a postoperative nomogram for the prediction of disease-
specific survival in patients with papillary renal cell carcinoma using a large
multicenter database. Int J Clin Oncol. 2020 Jan;25(1):145-150. doi:
10.1007/s10147-019-01530-x. Epub 2019 Aug 30. PMID: 31471787.
218: González J, Gaynor JJ, Martínez-Salamanca JI, CAPITANIO U, Tilki D,
Carballido JA, Chantada V, Daneshmand S, Evans CP, Gasch C, Gontero P, Haferkamp
A, Huang WC, Espinós EL, Master VA, McKiernan JM, Montorsi F, Pahernik S, Palou
J, Pruthi RS, Rodriguez-Faba O, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone
C, Vera-Donoso C, Zigeuner R, Hohenfellner M, Libertino JA, Ciancio G.
Association of an organ transplant-based approach with a dramatic reduction in
postoperative complications following radical nephrectomy and tumor thrombectomy
in renal cell carcinoma. Eur J Surg Oncol. 2019 Oct;45(10):1983-1992. doi:
10.1016/j.ejso.2019.05.009. Epub 2019 May 15. PMID: 31155470; PMCID: PMC8404534.
219: CAPITANIO U, Larcher A, Kriegmair MC, Bertolo R, Salagierski M, Campi R,
Klatte T, Trevisani F, Montorsi F, Mir MC, Ouzaid I; Kidney Cancer Working Group
of the Young Academic Urologists Working Party of the European Association of
Urology. Do We Truly Care About the Functional Outcomes for Renal Cancer
Patients? Multidisciplinarity Is Still Far Away. Eur Urol. 2019
Feb;75(2):349-350. doi: 10.1016/j.eururo.2018.08.040. Epub 2018 Sep 17. PMID:
30237026.
220: Borregales LD, Pecoraro A, Roussel E, Mari A, Grosso AA, Checcucci E,
Montorsi F, Larcher A, Van Poppel H, Porpiglia F, CAPITANIO U, Minervini A,
Albersen M, Serni S, Amparore D, Campi R. Morbidity of elective surgery for
localized renal masses among elderly patients: A contemporary multicenter study.
Eur J Surg Oncol. 2023 Aug 9;49(10):107014. doi: 10.1016/j.ejso.2023.107014.
Epub ahead of print. PMID: 37573666.
221: Bertolo R, Campi R, Mir MC, Klatte T, Kriegmair MC, Salagierski M, Ouzaid
I, CAPITANIO U; Young Academic Urologists Kidney Cancer Working Group of the
European Urological Association. Systematic Review and Pooled Analysis of the
Impact of Renorrhaphy Techniques on Renal Functional Outcome After Partial
Nephrectomy. Eur Urol Oncol. 2019 Sep;2(5):572-575. doi:
10.1016/j.euo.2018.11.008. Epub 2018 Dec 9. PMID: 31412012.
222: Montorsi F, Larcher A, CAPITANIO U. Re: Rohann J.M. Correa, Alexander V.
Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative
Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-
Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2019.06.002.
Eur Urol Focus. 2021 Mar;7(2):406. doi: 10.1016/j.euf.2019.08.018. Epub 2019 Sep
26. PMID: 31564640.
223: CAPITANIO U, Larcher A, Dell'Oglio P, Montorsi F. Re: Brian I. Rini, Tanya
B. Dorff, Paul Elson, et al. Active Surveillance in Metastatic Renal-cell
Carcinoma: A Prospective, Phase 2 Trial. Lancet Oncol Lancet 2016;17:1317-24:
Active Surveillance in Metastatic Renal Cell Carcinoma: Option or Exception? Eur
Urol. 2017 May;71(5):e139-e140. doi: 10.1016/j.eururo.2016.09.034. Epub 2016 Sep
29. PMID: 27692706.
224: Muttin F, CAPITANIO U, Montorsi F, Larcher A. Re: Ricardo G. Alvim,
François Audenet, Emily A. Vertosick, Daniel D. Sjoberg, Karim A. Touijer.
Performance Prediction for Surgical Outcomes in Partial Nephrectomy Using
Nephrometry Scores: A Comparison of Arterial Based Complexity (ABC), RENAL, and
PADUA Systems. Eur Urol Oncol 2018;1:428-34: Nephrometry Score: Quantifying the
Complexity of the Tumor or Struggling with the Complexity of the Score? Eur Urol
Oncol. 2019 Mar;2(2):228-229. doi: 10.1016/j.euo.2019.01.011. Epub 2019 Jan 30.
PMID: 31017103.
225: CAPITANIO U, Dell'Oglio P, Larcher A, Montorsi F. Reply to Kazutaka Saito's
Words of Wisdom re: Nephron-sparing Techniques Independently Decrease the Risk
of Cardiovascular Events Relative to Radical Nephrectomy in Patients with a
T1a-T1b Renal Mass and Normal Preoperative Renal Function. Eur Urol.
2016;69:538. Eur Urol. 2016 Nov;70(5):e135. doi: 10.1016/j.eururo.2016.04.014.
Epub 2016 Apr 27. PMID: 27131952.
226: Pruthi DK, Miller G, Ankerst DP, Neumair M, CAPITANIO U, Correa AF, Lane
BR, Roussel E, McGregor TB, Derweesh IH, Cordeiro M, Pierorazio PM, Calvo C, Bi
H, Noyes SL, Meagher M, Kutikov A, Uzzo RG, Van Poppel H, Larcher A, Montorsi F,
Kattan MW, Kaushik D, Liss MA. Diabetes, Obesity, and Pathologic Upstaging in
Renal Cell Carcinoma: Results from a large multi-institutional consortium. J
Urol. 2023 Aug 14:101097JU0000000000003650. doi: 10.1097/JU.0000000000003650.
Epub ahead of print. PMID: 37579345.
227: CAPITANIO U, Briganti A. Words of wisdom. Re: Surgical outcomes in the
management of isolated nodal recurrences: a multicenter, international
retrospective cohort. Eur Urol. 2015 May;67(5):974-5. doi:
10.1016/j.eururo.2014.12.064. PMID: 25845960.
228: CAPITANIO U, Gandaglia G, Larcher A, Montorsi F. Oncologic Surveillance for
Renal Cell Carcinoma: What Is Still Needed? Eur Urol. 2016 Nov;70(5):899-900.
doi: 10.1016/j.eururo.2016.03.030. Epub 2016 Mar 25. PMID: 27021796.